JPS6317068B2 - - Google Patents
Info
- Publication number
- JPS6317068B2 JPS6317068B2 JP54099524A JP9952479A JPS6317068B2 JP S6317068 B2 JPS6317068 B2 JP S6317068B2 JP 54099524 A JP54099524 A JP 54099524A JP 9952479 A JP9952479 A JP 9952479A JP S6317068 B2 JPS6317068 B2 JP S6317068B2
- Authority
- JP
- Japan
- Prior art keywords
- lower alkyl
- methyl
- formula
- ester
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- -1 1,4-dihydropyridazine-3-carbonyl Chemical group 0.000 claims description 64
- 125000000217 alkyl group Chemical group 0.000 claims description 25
- 150000002148 esters Chemical class 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 8
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 150000001768 cations Chemical group 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 125000001188 haloalkyl group Chemical group 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 125000004076 pyridyl group Chemical group 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical group 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 16
- VVFXLJCJOPOIFO-UHFFFAOYSA-N 1,4-dihydropyridazine-3-carboxylic acid Chemical class OC(=O)C1=NNC=CC1 VVFXLJCJOPOIFO-UHFFFAOYSA-N 0.000 abstract description 7
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 5
- 239000000812 cholinergic antagonist Substances 0.000 abstract description 3
- 230000002048 spasmolytic effect Effects 0.000 abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 54
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- 238000002844 melting Methods 0.000 description 35
- 230000008018 melting Effects 0.000 description 35
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 31
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 29
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 29
- 235000019441 ethanol Nutrition 0.000 description 23
- 159000000000 sodium salts Chemical class 0.000 description 23
- 239000003814 drug Substances 0.000 description 22
- 239000003085 diluting agent Substances 0.000 description 20
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 239000000825 pharmaceutical preparation Substances 0.000 description 14
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000000741 silica gel Substances 0.000 description 9
- 229910002027 silica gel Inorganic materials 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- NTCNSIFTFKBJIN-UHFFFAOYSA-N 1,4-dihydropyridazine-3,5-dicarboxylic acid Chemical compound OC(=O)C1=CNN=C(C(O)=O)C1 NTCNSIFTFKBJIN-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000454 talc Substances 0.000 description 5
- 235000012222 talc Nutrition 0.000 description 5
- 229910052623 talc Inorganic materials 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- MDKLAOSKCVGSQH-UHFFFAOYSA-N diethyl 6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=NNC(C)=C(C(=O)OCC)C1C1=CC=CC([N+]([O-])=O)=C1 MDKLAOSKCVGSQH-UHFFFAOYSA-N 0.000 description 4
- 239000008298 dragée Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000007127 saponification reaction Methods 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- HZVGMPJZVYBYEK-UHFFFAOYSA-N 1,4-dihydropyridazine Chemical group C1C=CNN=C1 HZVGMPJZVYBYEK-UHFFFAOYSA-N 0.000 description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 235000012216 bentonite Nutrition 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- HHCCNQLNWSZWDH-UHFFFAOYSA-N n-hydroxymethanimine oxide Chemical compound O[N+]([O-])=C HHCCNQLNWSZWDH-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 238000005809 transesterification reaction Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- RYMXOSNDOSCBNY-UHFFFAOYSA-N 4-(3-chlorophenyl)-6-methyl-1,4-dihydropyridazine-3,5-dicarboxylic acid Chemical compound OC(=O)C1=NNC(C)=C(C(O)=O)C1C1=CC=CC(Cl)=C1 RYMXOSNDOSCBNY-UHFFFAOYSA-N 0.000 description 2
- NVXDPDVZCQQHGZ-UHFFFAOYSA-N 5-o-ethyl 3-o-methyl 4-(3-chlorophenyl)-6-methyl-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NN=C(C(=O)OC)C1C1=CC=CC(Cl)=C1 NVXDPDVZCQQHGZ-UHFFFAOYSA-N 0.000 description 2
- KWWSZKJDQNAZRG-UHFFFAOYSA-N 6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridazine-3,5-dicarboxylic acid Chemical compound OC(=O)C1=NNC(C)=C(C(O)=O)C1C1=CC=CC([N+]([O-])=O)=C1 KWWSZKJDQNAZRG-UHFFFAOYSA-N 0.000 description 2
- NOXDJHKVJGRDNG-UHFFFAOYSA-N 6-methyl-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridazine-3,5-dicarboxylic acid Chemical compound OC(=O)C1=NNC(C)=C(C(O)=O)C1C1=CC=CC=C1C(F)(F)F NOXDJHKVJGRDNG-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 240000002470 Amphicarpaea bracteata Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 230000009435 amidation Effects 0.000 description 2
- 238000007112 amidation reaction Methods 0.000 description 2
- 230000002921 anti-spasmodic effect Effects 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 229940030600 antihypertensive agent Drugs 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- BARMLROCTIMJIE-UHFFFAOYSA-N 1-ethoxy-4-ethoxycarbonyl-n-hydroxy-3-(2-nitrophenyl)-1,5-dioxohexan-2-imine oxide Chemical compound CCOC(=O)C(C(C)=O)C(C(C(=O)OCC)=[N+](O)[O-])C1=CC=CC=C1[N+]([O-])=O BARMLROCTIMJIE-UHFFFAOYSA-N 0.000 description 1
- LNXWPJTXAJRWHG-UHFFFAOYSA-N 1-ethoxy-n-hydroxy-3-(3-nitrophenyl)-1,5-dioxohexan-2-imine oxide Chemical compound CCOC(=O)C(=[N+](O)[O-])C(CC(C)=O)C1=CC=CC([N+]([O-])=O)=C1 LNXWPJTXAJRWHG-UHFFFAOYSA-N 0.000 description 1
- FGOJCPKOOGIRPA-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 5-oxoazepane-1,4-dicarboxylate Chemical compound CCOC(=O)C1CCN(C(=O)OC(C)(C)C)CCC1=O FGOJCPKOOGIRPA-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- YWFNMJOPOFSOLX-UHFFFAOYSA-N 3-o-ethyl 5-o-methyl 4-(3-chloro-4-methylphenyl)-6-methyl-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=NNC(C)=C(C(=O)OC)C1C1=CC=C(C)C(Cl)=C1 YWFNMJOPOFSOLX-UHFFFAOYSA-N 0.000 description 1
- YLHDTPIFNQQVMR-UHFFFAOYSA-N 3-o-ethyl 5-o-methyl 6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=NNC(C)=C(C(=O)OC)C1C1=CC=CC([N+]([O-])=O)=C1 YLHDTPIFNQQVMR-UHFFFAOYSA-N 0.000 description 1
- YXSNCCXAJNWTSO-UHFFFAOYSA-N 4-(3-chlorophenyl)-5-ethoxycarbonyl-6-methyl-1,4-dihydropyridazine-3-carboxylic acid Chemical compound CCOC(=O)C1=C(C)NN=C(C(O)=O)C1C1=CC=CC(Cl)=C1 YXSNCCXAJNWTSO-UHFFFAOYSA-N 0.000 description 1
- OQUNJERPDFPBTR-UHFFFAOYSA-N 5-o-(2-methoxyethyl) 3-o-propan-2-yl 6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NN=C(C(=O)OC(C)C)C1C1=CC=CC([N+]([O-])=O)=C1 OQUNJERPDFPBTR-UHFFFAOYSA-N 0.000 description 1
- LCVYRTZEHJUMEB-UHFFFAOYSA-N 5-o-ethyl 3-o-methyl 6-methyl-4-(4-nitrophenyl)-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NN=C(C(=O)OC)C1C1=CC=C([N+]([O-])=O)C=C1 LCVYRTZEHJUMEB-UHFFFAOYSA-N 0.000 description 1
- MSVZVXOFXDRCAA-UHFFFAOYSA-N 6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridazine-3-carboxylic acid Chemical compound OC(=O)C1=NNC(C)=CC1C1=CC=CC([N+]([O-])=O)=C1 MSVZVXOFXDRCAA-UHFFFAOYSA-N 0.000 description 1
- HNRISMDEXDJNSN-UHFFFAOYSA-N 6-methyl-4-(3-nitrophenyl)-5-propan-2-yloxycarbonyl-1,4-dihydropyridazine-3-carboxylic acid Chemical compound CC(C)OC(=O)C1=C(C)NN=C(C(O)=O)C1C1=CC=CC([N+]([O-])=O)=C1 HNRISMDEXDJNSN-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000000073 Amphicarpaea bracteata Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003440 anti-fibrillation Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124575 antispasmodic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000005228 aryl sulfonate group Chemical group 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000005815 base catalysis Methods 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- PAQQINQUYUHCFY-UHFFFAOYSA-N bis(2-butoxyethyl) 4-(3-ethylphenyl)-6-methyl-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound CCCCOCCOC(=O)C1=NNC(C)=C(C(=O)OCCOCCCC)C1C1=CC=CC(CC)=C1 PAQQINQUYUHCFY-UHFFFAOYSA-N 0.000 description 1
- PLNTUEQZXZLDOJ-UHFFFAOYSA-N bis(2-methoxyethyl) 4-(3-bromophenyl)-6-methyl-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=NNC(C)=C(C(=O)OCCOC)C1C1=CC=CC(Br)=C1 PLNTUEQZXZLDOJ-UHFFFAOYSA-N 0.000 description 1
- IGHWFJLXXWLGPT-UHFFFAOYSA-N bis(2-methoxyethyl) 6-methyl-4-pyridin-4-yl-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=NNC(C)=C(C(=O)OCCOC)C1C1=CC=NC=C1 IGHWFJLXXWLGPT-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 206010007776 catatonia Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- RFSQQEPVQJWOQO-UHFFFAOYSA-N dimethyl 4-(2,6-dichlorophenyl)-6-methyl-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound COC(=O)C1=NNC(C)=C(C(=O)OC)C1C1=C(Cl)C=CC=C1Cl RFSQQEPVQJWOQO-UHFFFAOYSA-N 0.000 description 1
- GWPRHYZIPNRUQW-UHFFFAOYSA-N dimethyl 4-(2-chloro-5-nitrophenyl)-6-methyl-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound COC(=O)C1=NNC(C)=C(C(=O)OC)C1C1=CC([N+]([O-])=O)=CC=C1Cl GWPRHYZIPNRUQW-UHFFFAOYSA-N 0.000 description 1
- FRVZFWGXOWOJKM-UHFFFAOYSA-N dimethyl 6-methyl-4-(2-nitrophenyl)-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound COC(=O)C1=NNC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O FRVZFWGXOWOJKM-UHFFFAOYSA-N 0.000 description 1
- RWDPPMRCUNOHRT-UHFFFAOYSA-N dimethyl 6-methyl-4-phenyl-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound COC(=O)C1=NNC(C)=C(C(=O)OC)C1C1=CC=CC=C1 RWDPPMRCUNOHRT-UHFFFAOYSA-N 0.000 description 1
- XTDYIOOONNVFMA-UHFFFAOYSA-N dimethyl pentanedioate Chemical compound COC(=O)CCCC(=O)OC XTDYIOOONNVFMA-UHFFFAOYSA-N 0.000 description 1
- FIFYEQUUWIXEJH-UHFFFAOYSA-N dipropan-2-yl 4-(3,4-dichlorophenyl)-6-methyl-1,4-dihydropyridazine-3,5-dicarboxylate Chemical compound CC(C)OC(=O)C1=NNC(C)=C(C(=O)OC(C)C)C1C1=CC=C(Cl)C(Cl)=C1 FIFYEQUUWIXEJH-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- WRQGPGZATPOHHX-UHFFFAOYSA-N ethyl 2-oxohexanoate Chemical compound CCCCC(=O)C(=O)OCC WRQGPGZATPOHHX-UHFFFAOYSA-N 0.000 description 1
- ONRDSXUOKNQMBV-UHFFFAOYSA-N ethyl 4-(3-chlorophenyl)-3-[(3-chlorophenyl)carbamoyl]-6-methyl-1,4-dihydropyridazine-5-carboxylate Chemical compound CCOC(=O)C1=C(C)NN=C(C(=O)NC=2C=C(Cl)C=CC=2)C1C1=CC=CC(Cl)=C1 ONRDSXUOKNQMBV-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- KUDPGZONDFORKU-UHFFFAOYSA-N n-chloroaniline Chemical compound ClNC1=CC=CC=C1 KUDPGZONDFORKU-UHFFFAOYSA-N 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000012439 solid excipient Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
æ¬çºæã¯æ°èŠã®ïŒïŒïŒâãžãããããªããžã³â
ïŒâã«ã«ãã³é žèªå°äœããã®è£œé æ¹æ³äžŠã³ã«åŸªç°
åšã«åœ±é¿ãæãäžã€é®çïŒspasmolyticïŒåã³æ
ççäœçšãæããè¬å€ãšããŠã®ãã®çšéã«é¢ã
ãã ïŒïŒïŒâãžãããããªããžã³ã眮æãããïŒïŒ
ïŒâãžã«ã«ããã«ååç©ãããã©ãžã³æ°Žåç©ãšå
å¿ãããå Žåã«åŸãããããšã¯ãã§ã«æããã«ã
ããŠãããW.Borscheåã³M.SpannagelïŒ
Liebigs Ann.Chem.331ïŒ300ïŒ1904ïŒåç §ãããã
ããªãããå®éšã«ããã°ããšã¹ãã«åã³ã¢ã·ã«çœ®
æåºã«ãã€ãŠæ°åã®ã«ã«ããã«åºãååäžã«å°å ¥
ããå ŽåããããïŒïŒïŒâãžã«ã«ããã«ååç©ã®
補é ã®å®¹æãã«é床ããããé©ããã¹ãããšã«ã
ä»åãåå¿ã®ä»®å®ãããäžé段éãšããŠãããã
ååç©ããã®å Žã§ããã©ãžã³ãšåå¿ãããŠæ¬çºæ
ã«ãããïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«
ãã³é žãšã¹ãã«ãçæãããããšã«æåããã æ¬çºæã«åŸãã°ãäžè¬åŒ åŒäžã R1ã¯åŒOR5ãŸãã¯
ïŒâã«ã«ãã³é žèªå°äœããã®è£œé æ¹æ³äžŠã³ã«åŸªç°
åšã«åœ±é¿ãæãäžã€é®çïŒspasmolyticïŒåã³æ
ççäœçšãæããè¬å€ãšããŠã®ãã®çšéã«é¢ã
ãã ïŒïŒïŒâãžãããããªããžã³ã眮æãããïŒïŒ
ïŒâãžã«ã«ããã«ååç©ãããã©ãžã³æ°Žåç©ãšå
å¿ãããå Žåã«åŸãããããšã¯ãã§ã«æããã«ã
ããŠãããW.Borscheåã³M.SpannagelïŒ
Liebigs Ann.Chem.331ïŒ300ïŒ1904ïŒåç §ãããã
ããªãããå®éšã«ããã°ããšã¹ãã«åã³ã¢ã·ã«çœ®
æåºã«ãã€ãŠæ°åã®ã«ã«ããã«åºãååäžã«å°å ¥
ããå ŽåããããïŒïŒïŒâãžã«ã«ããã«ååç©ã®
補é ã®å®¹æãã«é床ããããé©ããã¹ãããšã«ã
ä»åãåå¿ã®ä»®å®ãããäžé段éãšããŠãããã
ååç©ããã®å Žã§ããã©ãžã³ãšåå¿ãããŠæ¬çºæ
ã«ãããïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«
ãã³é žãšã¹ãã«ãçæãããããšã«æåããã æ¬çºæã«åŸãã°ãäžè¬åŒ åŒäžã R1ã¯åŒOR5ãŸãã¯
ãåŒãã®åºãè¡šããã
ããã§ã
R5ã¯æ°ŽçŽ ååãäœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ã
ã·ã¢ã«ãã«ãéæäœçŽã¢ã«ãã«ã§çœ®æãããŠããŠ
ãããã·ã¯ãã¢ã«ãã«ãäœçŽã¢ã«ã±ãã«ããŸãã¯
âäœçŽã¢ã«ãã«ââãã³ãžã«ã¢ããäœçŽã¢ã«
ãã«ãè¡šããããã㊠R6åã³R7ã¯çžç°ãªããåã æ°ŽçŽ ååãäœçŽã¢
ã«ãã«ãéæããã²ã³ååã§çœ®æãããŠããŠãã
ãããšãã«ããŸãã¯ãã³ãžã«ãè¡šããïŒ R2ã¯éæäœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ãã·ãã
ãã²ã³ãããªãã«ãªãã¡ãã«ãã·ã¢ããããã¯ã
ããã§çœ®æãããŠããŠãããããšãã«ãããšãã«
ãŸãã¯ããªãžã«ãè¡šããïŒ R3ã¯æ°ŽçŽ ååãŸãã¯åŒCOOR8ã®åºãè¡šããã
ãã㧠R8ã¯æ°ŽçŽ ååãäœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ã
ã·ã¢ã«ãã«ãŸãã¯äœçŽããã¢ã«ãã«ãè¡šããïŒã
ã㊠R4ã¯äœçŽã¢ã«ãã«ãŸãã¯ããšãã«ãè¡šããã ã®ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«ããã«
ååç©ãæäŸãããã æ¬çºæã«ãããååç©ã¯ã埪ç°åšç³»
ïŒcirculationïŒã®åŠçœ®äžŠã³ã«èè žç®¡ãæ³å°¿çæ®åš
管åã³åŒåžåšç®¡ç³»ã®åŠçœ®ã«æçšãªæ°èŠãªçŸ€ã®ç©è³ª
ã§ããããããŠãŸãæ¬ååç©ã¯æççäœçšãæã
ããããããŠæ¬ååç©ã¯è¬å€ã®åéã«ãããŠäŸ¡å€
ãããã®ãšã¿ãªãåŸãã ãŸããæ¬çºæã«åŸãã°ãäžè¬åŒ åŒäžã R1â²ã¯åŒOR5â²ã®åºãè¡šããããã㧠R5â²ã¯äœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ãã·ã¢ã«ãã«ã
éæäœçŽã¢ã«ãã«ã§çœ®æãããŠããŠãããã·ã¯ã
ã¢ã«ãã«ããŸãã¯äœçŽã¢ã«ã±ãã«ãè¡šããïŒ R2ïŒR3åã³R4ã¯åèšã®æå³ãæãïŒãã㊠ã¯ã«ããªã³ãè¡šããïŒç¹ã«ïŒäŸ¡ã®ã«ããªã³ïŒ
äŸãã°æ°ŽçŽ ã€ãªã³ããŸãã¯ã¢ã«ã«ãªéå±ïŒæ®ã«ã
ããªãŠã ãŸãã¯ã«ãªãŠã ïŒãã¢ã³ã¢ããŠã ããã
ã¯ã¢ã«ãã«ã¢ã³ã¢ããŠã ã€ãªã³ãè¡šããã ã®ãããã³é žãäžæŽ»æ§ææ©æº¶åªäžã§ãŸããªãŸã³ãš
åå¿ããN.Kornblumåã³P.A.WabeïŒJ.Org.
Chem.ïŒ38ïŒ1418é 以äžïŒ1973ïŒåç §ïŒœã次ãã§
åŒ ã®ããã©ãžã³ãŸãã¯ããã©ãžã³æ°Žåç©ãšåå¿ãã
ãããšãããªãæ¬çºæã®ååç©ã®è£œé æ¹æ³ãæäŸ
ãããã ããã«ãçããååç©ãããã±ã³åããšã¹ãã«
åããšã¹ãã«äº€æãŸãã¯ã¢ããåã®äžè¬ã«æ¢ç¥ã®
æ¹æ³ã«ãã€ãŠãæ¬çºæã®åŒïŒïŒã®ä»ã®ååç©ã
éæçæãããããšãã§ããã æ¬çºæã«ãããæ°èŠãªïŒïŒïŒâãžãããããªã
ãžã³é¡ã¯äŸ¡å€ããè¬çåŠçç¹æ§ãæããããã®åŸª
ç°åšç³»ã«åãŒãäœçšãé®çïŒSpasmolyticïŒäœçš
åã³æççäœçšã«åºã¥ããæ¬ååç©ã¯æé«è¡å§å€
ïŒantiâhypertensive agentïŒãè¡ç®¡æ¡åŒµå€
ïŒvasodilatorïŒãå åèæ²»çå€ïŒcoronary
therapeuticsïŒãé®çå€åã³æ¶çå€ïŒantiâ
Phlogistic agentïŒãšããŠçšããããšãã§ããã åºçºç©è³ªãšããŠãïŒâã¢ã»ãã«âïŒâaciâã
ããâïŒâïŒïŒâãããããšãã«ïŒâã°ã«ã¿ã«é ž
ãžãšãã«ãšã¹ãã«ã®ãããªãŠã å¡©ããªãŸã³åã³ã
ãã©ãžã³ãçšããå Žåããã®åå¿éçšã¯äŸãšããŠ
次ã®åå¿åŒã«ãã€ãŠç€ºãããšãã§ããã äžèšã®æ¹æ³ã«ããã°ãåŒïŒïŒïŒïŒžïŒïŒšïŒã®ã
ããã³é žãŸãã¯ãã®å¡©ããŸããªãŸã³ãšåå¿ããã
次ã«ãã®çæç©ãããã©ãžã³ãšåå¿ãããŠãåŒ
ïŒïŒã®ïŒïŒïŒâãžãããããªããžã³èªå°äœãç
æãããã æ¬çºæã«åŸã€ãŠåºçºç©è³ªãšããŠçšãããããã³
é žåã³ãã®å¡©ã¯ãäŸãã°ãã€ãªãã³âã«ã«ããã«
ååç©äžãžã®ãããé ¢é žãšã¹ãã«ã®å¡©åºâ觊åªäœ
çšã«ãããã«ãšã«ïŒMichaelïŒä»å ã«ãã€ãŠè£œé
ããããšãã§ããA.Dornowåã³A.FreseïŒ
Ann.Chem.578ïŒ122ïŒ1952ïŒåç §ïŒœã æãåŸãåºçºç©è³ªã®äŸã¯æ¬¡ã®ãã®ã§ããïŒ ïŒâaciâãããâïŒâïŒïŒâãããããšãã«ïŒ
âïŒâãªããœâãããµã³é žãšãã«ãšã¹ãã«ãïŒâ
aciâãããâïŒâãªããœâïŒâïŒïŒâããªãã«
ãªãã¡ãã«ããšãã«ïŒâããã¿ã³é žã·ã¯ããã³ã
ã«ãšã¹ãã«ã®ãããªãŠã å¡©ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¯ããããšãã«ïŒâïŒ
âãªããœâãããµã³é žãšãã«ãšã¹ãã«ã®ãžãšãã«
ã¢ã³ã¢ããŠã å¡©ãåã³ïŒâã¢ã»ãã«âïŒâaciâ
ãããâïŒâããªãžã³âïŒâã€ã«âã°ã«ã¿ã«é žïŒ
âïŒÎ²âã¡ããã·ãšãã«ïŒïŒâã¡ãã«ãšã¹ãã«ã®
ãããªãŠã å¡©ã å¯èœãªåžéå€ã¯å šãŠã®äžæŽ»æ§ææ©æº¶åªã§ããã
ãããã®äžã«ã¯ã奜ãŸããã¯ãã¢ã«ã³ãŒã«äŸãã°
ãšã¿ããŒã«ãã¡ã¿ããŒã«åã³ã€ãœãããããŒã«ïŒ
ãšãŒãã«äŸãã°ãžãªããµã³ããžãšãã«ãšãŒãã«ã
ããã©ããããã©ã³ãã°ãªã³ãŒã«ã¢ãã¡ãã«ãšãŒ
ãã«ãããã¯ã°ãªã³ãŒã«ãžã¡ãã«ãšãŒãã«ïŒãŸã
ã¯ãžã¡ãã«ãã«ã ã¢ããããžã¡ãã«ã¹ã«ããã·
ããã¢ã»ããããªã«ãããªãžã³äžŠã³ã«ãããµã¡ã
ã«ãªã³é žããªã¢ãããªã©ãå«ãŸããã åå¿æž©åºŠã¯å®è³ªçãªç¯å²å ã§å€ããããšãã§ã
ããäžè¬ã«ãã®åå¿â120âä¹è³ïŒ120âéã奜ãŸ
ããã¯â80âä¹è³ïŒ20âéã®ç¯å²ã§è¡ãããã ãã®åå¿ã¯åžžå§äžã§è¡ãããšãã§ãããããã
ããŸãå å§äžã§ãè¡ãããšãã§ãããäžè¬ã«åå¿
ã¯åžžå§äžã§è¡ãããã æ¬çºæã«ãããæ¹æ³ãè¡ãéã«ãåŒïŒïŒã®å
åç©ããŸãé©åœãªæº¶åªäžã«ãŠäœæž©ã§ãªãŸã³åãã
次ã«ãã®çæç©ã宀枩ã§ããã©ãžã³ãŸãã¯ããã©
ãžã³æ°Žåç©ïŒã¢ã«ãšåå¿ãããã æ¬çºæã«ãããç©è³ªã®åé¢åã³ç²Ÿè£œã¯å¥œãŸãã
ã¯ãé©åœã«ã¯äžæº¶æ§ç©è³ªãåé¢ããåŸã溶åªãç
空äžã§çå»ããã¯ãããã°ã©ãã€ãŒã«ãããåŸã«
çµæ¶ç¶æ ã§åŸãããçæç©ãé©åœãªæº¶åªããåçµ
æ¶ãããæ¹æ³ã§è¡ãããã äžèšã®æ¹æ³ã«å ããŠãæŽã«ãæ¬çºæã«ãããå
åç©ã¯ãæ¬çºæã«ãããäžèšã®æ¹æ³ã«ãã€ãŠåŸã
ããïŒïŒïŒâãžãããããªããžã³âã¢ãâåã³ãž
ã«ã«ãã³é žãšã¹ãã«ãããæç®ã«ããæ¢ç¥ã®ã±ã³
åããšã¹ãã«åããšã¹ãã«äº€æãŸãã¯ã¢ããåæ³
OrganikumïŒVEB Deuyscher Verlag der
WissenschaftenïŒBerlin1967åç §ïŒã«ãã€ãŠé©
åœã«è£œé ããããšãã§ããã 次ã®æ¹æ³ã¯ããã«é¢ããåãªãäŸãšããŠç€ºãã
ãšãã§ããïŒ ïœ ã±ã³å ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«ãã³é ž
ãšã¹ãã«ïŒåŒïŒR1ïŒOR5ïŒåã³ïŒïŒïŒâãžã
ããããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãšã¹ãã«
ïŒåŒïŒR1ïŒOR5ïŒR3ïŒCOOR8ïŒãã¢ã«ã«ãªïŒ
åœéã§éžæçã«ã±ã³åããïŒïŒïŒâãžãããããª
ããžã³âïŒâã«ã«ãã³é žïŒåŒïŒR1ïŒOHïŒãç
æãããããšãã§ãããéå°éã®ã¢ã«ã«ã§ã®ã±ã³
åã«ãããïŒïŒïŒâãžãããããªããžã³âïŒïŒïŒ
âãžã«ã«ãã³é žïŒåŒïŒR1ïŒOHïŒR3ïŒCOOHïŒ
ãèªå°ãããã ïœ ãšã¹ãã«å ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«ãã³é ž
ïŒåŒïŒR1ïŒOHïŒãïŒïŒïŒâãžãããããªããžã³
âïŒïŒïŒâãžã«ã«ãã³é žããŒããšã¹ãã«ïŒåŒïŒ
R1ïŒOHïŒR3ïŒCOOR8ãŸãã¯R1ïŒOR5ïŒR3ïŒ
COOHïŒåã³ïŒïŒïŒâãžãããããªããžã³âïŒïŒ
ïŒâãžã«ã«ãã³é žïŒåŒïŒR1ïŒOHïŒR3ïŒ
COOHïŒãã¢ã«ã³ãŒã«ããžã¢ãŸã¢ã«ã«ã³ããžã¢
ã«ãã«ã¹ã«ããšãŒããŸãã¯ã¢ã«ãã«ãã©ã€ããšå
å¿ããã察å¿ãããšã¹ãã«ïŒåŒïŒR1ïŒOR5ïŒ
ãŸãã¯R1ïŒOR5ïŒR3ïŒCOOR8ïŒãçæãããã
ãšãã§ããã ïœ ãšã¹ãã«äº€æ ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«ãã³é ž
ãšã¹ãã«ïŒåŒïŒR1ïŒOR5ïŒãåã³ïŒïŒïŒâãžã
ããããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãšã¹ãã«
ïŒåŒïŒR1ïŒOR5ïŒR3ïŒCOOR8ïŒãã¢ã«ã³ãŒã«
äžã«ãŠé žãŸãã¯å¡©åºè§Šåªäžã§åå¿ããã察å¿ãã
ãšã¹ãã«ãçæãããããšãã§ããã ïœ ã¢ããå ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«ãã³é ž
ïŒåŒïŒR1ïŒOHïŒãïŒïŒïŒâãžãããããªããžã³
âïŒâãžã«ã«ãã³é žãšã¹ãã«ïŒåŒïŒR1ïŒ
OR5ïŒãïŒïŒïŒâãžãããããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žããŒããšã¹ãã«ïŒåŒïŒR1ïŒOHïŒ
R3ïŒCOOR8ïŒãïŒïŒïŒâãžãããããªããžã³â
ïŒïŒïŒâãžã«ã«ãã³é žïŒåŒïŒR1ïŒOHïŒR3ïŒ
COOHïŒåã³ïŒïŒïŒâãžãããããªããžã³âïŒïŒ
ïŒâãžã«ã«ãã³é žãšã¹ãã«ïŒåŒïŒR1ïŒOR5ïŒ
R3ïŒCOOR8ïŒãé©åœãªæº¶åªäžã«ãŠç¬¬äžçŽãŸãã¯
第äºçŽèèªæãŸãã¯è³éŠæã¢ãã³ã§å¯Ÿå¿ããã¢ã
ããŸãã¯ããã©ãžãïŒåŒïŒR1ïŒNR6R7ãŸãã¯
R1ïŒNR6R7ïŒR3ïŒCOOR8ïŒã«è»¢åããããšãã§
ããã å¿è«ãäžèšã®æ¹æ³ã¯ã該åºã«å¯Ÿããç¹å®ã®æå³
ã®å€ã«ãæ¬çºæã«ãããä»ã®ååç©ã®è£œé ã«çšã
ãããšãã§ããã æ¬çºæã«ãããååç©ã¯ç«äœç°æ§äœåœ¢ã§ååš
ãããã®ãã®ã¯é¡åãšããŠæåããïŒãšãã³ããª
ããŒïŒããŸãã¯é¡åãšããŠæåããªãïŒãžã¢ã¹ã
ã¬ãªããŒïŒã®ãã®ã§ãããæ¬çºæã¯å¯Ÿæäœåã³ã©
ã»ã圢ã®åæ¹ã䞊ã³ã«ãžã¢ã¹ãã¬ãªããŒæ··åç©ã«
é¢ããããžã¢ã¹ãã¬ãªããŒãšåæ§ã«ãã©ã»ã圢ã¯
æ¢ç¥ã®æ¹æ³ã«ãããŠåäžã®ç«äœç°æ§äœã§ããåæ
åã«åå²ããããšãã§ããïŒäŸãã°E.L.ElielïŒ
Stereochemistry of Carbon CompoundsïŒ
McGraw HillïŒ1962åç §ïŒã åŸèšã®è£œé å®æœäŸã«å ããŠãæ¬çºæã«ãããŠæ¬¡
ã®æŽ»æ§ååç©ãæããããšãã§ããïŒïŒâãšãã«
ïŒïŒïŒâãžãããâïŒâïŒïŒâãããããšãã«ïŒ
âããªããã³âïŒâã«ã«ãã³é žãšãã«ãšã¹ãã«ã
ïŒâïŒïŒïŒïŒâãžã¯ããããšãã«ïŒâïŒïŒïŒâãž
ãããâïŒâã¡ãã«ããªããžã³âïŒïŒïŒâãžã«ã«
ãã³é žãžã¡ãã«ãšã¹ãã«ãïŒïŒïŒâãžãããâïŒ
âïŒïŒâãšãã«ããšãã«ïŒâïŒâã¡ãã«âããªã
ãžã³âïŒïŒïŒâãžã«ã«ãã³é žãžâïŒÎ²âïœâãã
ãã·ãšãã«ïŒãšã¹ãã«ãïŒâïŒïŒâããã¢ããšã
ã«ïŒâïŒïŒïŒâãžãããâïŒâã¡ãã«âããªããž
ã³âïŒïŒïŒâãžã«ã«ãã³é žãžïŒÎ²âã¡ããã·ãšã
ã«ïŒãšã¹ãã«ãïŒïŒïŒâãžãããâïŒâã¡ãã«â
ïŒâããªãžâïŒâã€ã«âããªããžã³âïŒïŒïŒâãž
ã«ã«ãã³é žãžïŒÎ²âã¡ããã·ãšãã«ïŒãšã¹ãã«ã
ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâããª
ãã«ãªãã¡ãã«ããšãã«ïŒâããªããžã³âïŒïŒïŒ
âãžã«ã«ãã³é žïŒâïŒÎ²âãžã¡ãã«ã¢ãããšã
ã«ïŒïŒâïŒÎ²âããªãã«ãªããã«ïŒãšã¹ãã«ã
ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâããªãžâïŒ
âã€ã«âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâ
ãšãã«ïŒâã¡ãã«ãšã¹ãã«ãïŒâïŒïŒïŒïŒâãžã¯
ããããšãã«ïŒâïŒïŒïŒâãžãããâïŒâã¡ãã«
âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžã€ãœãã
ãã«ãšã¹ãã«ãïŒïŒïŒâãžãããâïŒâïŒïŒïŒïŒ
âãžãããããšãã«ïŒâïŒâã¡ãã«âããªããžã³
âïŒïŒïŒâã«ã«ãã³é žãžãšãã«ãšã¹ãã«ãåã³ïŒ
âïŒïŒâã¯ããâïŒâã¡ãã«ããšãã«ïŒâïŒïŒïŒ
âãžãããâïŒâã¡ãã«âããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã æ¬çºæã«ãããååç©ã¯åºãäžã€çš®ã ã®ç¯å²ã®
è¬çåŠçäœçšãæããã 詳现ã«ã¯ãåç©å®éšã«ãããŠæ¬¡ã®äž»ãªäœçšãç«
蚌ãããïŒ ïŒ éçµå£çãçµå£çåã³èäžçã«æäžããéã
æ¬ååç©ã¯å ç¶èã®é¡èã§äžã€æç¶çãªæ¡åŒµã
èµ·ããããå ç¶èã«å¯Ÿãããã®äœçšã¯ãå¿èã«
ãããè² æ ãæžããåæçãªäºç¡é žå¡©
ïŒnitriteïŒæ§å¹æã«ãã€ãŠåŒ·ãããããæ¬åå
ç©ã¯ãšãã«ã®ãŒç¯çŽã®æå³ã§å¿è代è¬äœçš
ïŒheart metabolismïŒã«åœ±é¿ãäžããããŸãã¯
該äœçšãæ¹åããã ïŒ å¿èã«ãããåºæ¿çæïŒstimulus
formationïŒåã³è奮äŒéç³»ïŒexcitation
conduction systemïŒã®å¿åºæ§ïŒexcitabilityïŒ
ãæžããããåŸã€ãŠæ现åäœçšïŒantiâ
fibrillation actionïŒããããããããã¯æ²»ç
æè¬éã«ãããŠæ€åºããããšãã§ããã ïŒ è管ã®å¹³æ»çã®ç·åŒµç«ïŒtoneïŒãæ¬ååç©ã®
äœçšã«ããèããããæžããããããã®è管â
é®çäœçšã¯å šè管系ã«èµ·ãåŸãããæãã¯å€æ¥
ããè管é åïŒcircumseribed vascular
regionïŒïŒäŸãã°äžæ¢ç¥çµç³»ïŒã«ãããŠå€å°é
é¢ããŠè¡šãããã ïŒ æ¬ååç©ã¯æ®éç·åŒµååã³é«åºŠç·åŒµåã®åç©
ã®è¡å§ãäœäžãããåŸã€ãŠæé«è¡å§å€ãšããŠäœ¿
çšããããšãã§ããã ïŒ æ¬ååç©ã¯åŒ·åºŠã®çèâé®çäœçšãæããã
ã®äœçšã¯èãè žç®¡ãæ³å°¿çæ®åšåã³åŒåžåšç³»ã®
å¹³æ»çã«é¡èã«çŸãããã ïŒ æ¬ååç©ã¯æççäœçšãæããã äžèšã®åŠããæ¬çºæã¯ãŸãæ¬çºæã®ååç©ã®å»
è¬åã³ç£å»è¬ã«ãããçšéã«é¢ããã æ¬çºæã¯ã掻æ§æåãšããŠæ¬çºæã®ååç©ãã
åºäœãŸãã¯æ¶²åããæ°äœã®åžéå€æãã¯è¡šé¢æŽ»æ§
å€ãååšããå Žåãé€ããŠååé200ãããå°ã
ãïŒå¥œãŸããã¯350ãããå°ããïŒæº¶åªä»¥å€ã®æ¶²
äœåžéå€ãšã®æ··åç©ãšããŠå«æããè¬å€èª¿è£œç©ã
æäŸããã æŽã«æ¬çºæã¯ã掻æ§æåãšããŠæ¬çºæã®ååç©
ãç¡èãŸãã¯ççåŠçç匵氎溶液ã®åœ¢æ ã§å«æã
ãè¬å€èª¿è£œç©ãæäŸããã ãŸãæ¬çºæã¯æ¬çºæã®ååç©ãããªãæäžåäœ
圢æ ã«ãããè¬å€ãæäŸããã ãŸãæ¬çºæã¯æ¬çºæã®ååç©ãå«ãã§æãé å€
ãããŒã³ãžïŒlozengeïŒåã³é¡ç²ãå«ãããç³è¡£äžžã
ã«ãã»ã«å€ãäžžå€ãã¢ã³ãã«å€ãŸãã¯åè¬ã®åœ¢æ
ã«ãããè¬å€ãæäŸããã æ¬æ现æžã«ãããŠçšãããè¬å€ããšã¯ãå»è¬æ
äžã«é©ããç©ççã«åé¢ããäžäœã®éšåãæå³ã
ããæ¬æ现æžã«ãããŠçšãããæè¬åäœåœ¢æ ã«ã
ããè¬å€ããšã¯ãæ äœãšã®æ··åç©ãšããŠåã³ïŒãŸ
ãã¯ãšã³ãããïŒenvelopeïŒå ã«å«ãŸããæ¬çº
æã®ååç©ã®ïŒæ¥åœãã®æè¬éãŸãã¯ãã®åæ°
ïŒïŒåãŸã§ïŒãããã¯çŽæ°ïŒ1/40ãŸã§ïŒãåã å«
æããå»è¬æäžã«é©ããç©ççã«åé¢ããäžäœã®
éšåãæå³ããã該è¬å€ãïŒæ¥åœãã®æè¬éãå«
ããæãã¯äŸãã°ïŒæ¥åœãã®æè¬éã®1/2ïŒ1/3ã
ããã¯1/4ãå«ããã«ãã€ãŠãæäžããè¬å€ã¯ã
ãããïŒæ¥ïŒåãŸãã¯äŸãã°ïŒïŒïŒãããã¯ïŒå
ãšãªããã 該è¬å€èª¿è£œç©ã¯äŸãã°ã²ã«ãå¡åžå€ãã¯ãªãŒ
ã ãã¹ãã¬ãŒïŒãšãŒããŸã«ãå«ãïŒãããŒã·ãšã³ã
æ°Žæ§ãããã¯éæ°Žæ§åžéå€äžã®æŽ»æ§æåã®æžæ¿
液ã溶液åã³ä¹³æ¶²ãã·ããããé¡ç²ãŸãã¯ç²æ«ã®
圢æ ããšãããšãã§ããã é å€ãç³è¡£äžžãã«ãã»ã«å€åã³äžžå€ã«æ圢ãã
ããã«é©åãããè¬å€èª¿è£œç©ïŒäŸãã°ç²å€ïŒã«çš
ããåžéå€ãšããŠã¯æ¬¡ã®ãã®ãå«ãŸããïŒ (a)å å¡«å€åã³äŒžå±å€ãäŸãã°æŸ±ç²ãç ç³ããã³
ãããŒã«åã³ã±ã€é žïŒ(b)çµåå€ãäŸãã°ã«ã«ãã
ã·ã«ã¡ãã«ã»ã«ããŒã¹åã³ä»ã®ã»ã«ããŒã¹èªå°
äœãã¢ã«ã®ã³é žå¡©ããŒã©ãã³åã³ããªããã«ãã
ãªãã³ïŒ(c)湿最å€ãäŸãã°ã°ãªã»ãªã³ïŒ(d)厩å£å€
äŸãã°å¯å€©ãçé žã«ã«ã·ãŠã åã³éçé žãããªãŠ
ã ïŒ(e)溶解é 延å€ãäŸãã°ãã©ãã€ã³ïŒ(f)ååžå
ä¿é²å€ãäŸãã°ç¬¬åçŽã¢ã³ã¢ããŠã ååç©ïŒ(g)è¡š
é¢æŽ»æ§å€ãäŸãã°ã»ãã«ã¢ã«ã³ãŒã«ãã°ãªã»ãªã³
ã¢ãã¹ãã¢ã¬ãŒãïŒ(h)åžçæ äœãäŸãã°ã«ãªãªã³
åã³ãã³ããã€ãïŒ(i)最æ»å€ãäŸãã°ã¿ã«ã¯ãã¹
ãã¢ãªã³é žã«ã«ã·ãŠã åã³ã¹ãã¢ãªã³é žãã°ãã·
ãŠã 䞊ã³ã«åºäœã®ããªãšãã¬ã³ã°ãªã³ãŒã«ã æ¬çºæã®è¬å€èª¿è£œç©ããã€ãã€ãé å€ãç³è¡£
äžžãã«ãã»ã«å€åã³äžžå€ã¯ãæ®éã®è¢«èŠããšã³ã
ããåã³ä¿è·åºè³ªãæããããšãã§ãããããã¯
äžéæåå€ãå«ãããšãã§ããããããã¯æŽ»æ§æ
åã®ã¿ãæãã¯å¥œãŸããã¯è žç®¡ã®ç¹å®ã®éšåã«ã
ããŠãå¯èœãªãã°é·æéã«äºã€ãŠæŸåºããããã«
æ§æããããšãã§ããã被èŠããšã³ãããåã³ä¿
è·åºè³ªã¯äŸãã°éåäœç©è³ªãŸãã¯ããŠããã€ãã
ããšãã§ããã ãŸã掻æ§æåãäžèšåžéå€ã®ïŒçš®ãŸãã¯æ°çš®ãš
å ±ã«ãã€ã¯ãã«ãã»ã«ç¶ã«ã€ããããšãã§ããã åè¬ã«æ圢ããããã«é©ããè¬å€èª¿è£œç©ã«çšã
ãåžéå€ã¯ãäŸãã°æ®éã®æ°Žæº¶æ§ãŸãã¯é氎溶æ§
åžéå€ãäŸãã°ããªãšãã¬ã³ã°ãªã³ãŒã«åã³èèª
ïŒäŸãã°ãã³ã³ã¢æ²¹åã³é«çŽãšã¹ãã«ãäŸãã°C16
âèèªé žã«ããC14âã¢ã«ã³ãŒã«ãïŒãŸãã¯ããã
ã®åžéå€ã®æ··åç©ã§ããããšãã§ããã å¡åžå€ãã¯ãªãŒã åã³ã²ã«ã§ããè¬å€èª¿è£œç©ã«
ã¯ãäŸãã°æ®éã®åžéå€ãäŸãã°åç©æ§åã³æ€ç©
æ§èèªãããŠããã©ãã€ã³ã柱ç²ããã©ãã«ã³
ããã»ã«ããŒã¹èªå°äœãããªãšãã¬ã³ã°ãªã³ãŒ
ã«ãã·ãªã³ãŒã³ããã³ããã€ããã±ã€é žãã¿ã«ã¯
åã³é žåäºéãŸãã¯ãããã®ç©è³ªã®æ··åç©ãå«ãŸ
ããããšãã§ããã ç²å€åã³ã¹ãã¬ãŒã§ããè¬å€èª¿è£œç©ã«ã¯ãäŸã
ã°æ®éã®åžéå€ãäŸãã°ã©ã¯ããŒã¹ãã¿ã«ã¯ãã±
ã€é žãæ°Žé žåã¢ã«ãããŠã ãã±ã€é žã«ã«ã·ãŠã å
ã³ããªã¢ããç²æ«ãŸãã¯ãããã®ç©è³ªã®æ··åç©ã
å«ãŸããããšãã§ããããšãŒããŸã«ã¹ãã¬ãŒã«ã¯
äŸãã°æ®éã®åŽå°åºå€äŸãã°ã¯ãããã«ãªãçå
æ°ŽçŽ ãå«ãããããšãã§ããã 溶液åã³ä¹³æ¶²ã§ããè¬å€èª¿è£œç©ã«ã¯ãäŸãã°æ®
éã®åžéå€ïŒå¿è«ãè¡šé¢æŽ»æ§å€ãååšããå Žåã
é€ããŠãååé200以äžã®äžèšã®æº¶åªã¯é€å€ã
ãïŒãäŸãã°æº¶åªã溶解å€åã³ä¹³åå€ãå«ãŸãã
ããšãã§ããïŒãããåžéå€ã®ç¹å®ã®äŸã¯ãæ°Žã
ãšãã«ã¢ã«ã³ãŒã«ãã€ãœãããã«ã¢ã«ã³ãŒã«ãç
é žãšãã«ãé ¢é žãšãã«ããã³ãžã«ã¢ã«ã³ãŒã«ãã
ã³ãžã«ãã³ãŸãšãŒãããããã¬ã³ã°ãªã³ãŒã«ã
ïŒïŒïŒâããã¬ã³ã°ãªã³ãŒã«ããžã¡ãã«ãã«ã ã¢
ãããæ²¹ïŒäŸãã°ç²ç ããèœè±çæ²¹ïŒãã°ãªã»ãª
ã³ãããã©ãããããªããªã«ã¢ã«ã³ãŒã«ãããªãš
ãã¬ã³ã°ãªã³ãŒã«åã³ãœã«ãããŒã«ã®èèªé žãšã¹
ãã«ãŸãã¯ãããã®æ··åç©ã§ããã éçµå£æäžã«å¯ŸããŠã溶液åã³ä¹³æ¶²ã¯ç¡èã«ã
ããŠé©åœã«ã¯è¡æ¶²ç匵ã«ãã¹ãã§ããã æžæ¿æ¶²ã§ããè¬å€èª¿è£œç©ã«ã¯ãæ®éã®åžéå€ã
äŸãã°æ°Žããšãã«ã¢ã«ã³ãŒã«ããããã¬ã³ã°ãªã³
ãŒã«ãè¡šé¢æŽ»æ§å€ïŒäŸãã°ãšããã·ã«åã€ãœã¹ã
ã¢ãªã«ã¢ã«ã³ãŒã«ãããªãªãã·ãšãã¬ã³ãœã«ãã
ãåã³ãœã«ãã¿ã³ãšã¹ãã«ïŒã®åŠã液äœåžéå€ã
埮çµæ¶æ§ã»ã«ããŒã¹ãã¡ã¿æ°Žé žåã¢ã«ãããŠã ã
ãã³ããã€ããå¯å€©åã³ãã©ã¬ã«ã³ããŸãã¯ãã
ãã®æ··åç©ãå«ãŸããããšãã§ããã 奜é©ãªè³Šåœ¢å€ã®äŸã¯ãæ°Žãç¡æ¯æ§ã®ææ©æº¶åªäŸ
ãã°ãã©ãã€ã³ïŒäŸãã°ç³æ²¹çåïŒãæ€ç©æ²¹ïŒäŸ
ãã°èœè±çæ²¹ïŒãŽãæ²¹ïŒãã¢ã«ã³ãŒã«ïŒäŸãã°ãš
ãã«ã¢ã«ã³ãŒã«åã³ã°ãªã»ãªã³ïŒåã³ã°ãªã³ãŒã«
ïŒäŸãã°ãããã¬ã³ã°ãªã³ãŒã«åã³ããªãšãã¬ã³
ã°ãªã³ãŒã«ïŒãåºäœã®è³Šåœ¢å€äŸãã°å€©ç¶å²©ç³ç²æ«
ïŒäŸãã°ã«ãªãªã³ãã¢ã«ãããã¿ã«ã¯åã³ããšãŒ
ã¯ïŒãåæ岩ç³ç²æ«ïŒäŸãã°é«åæ£æ§ã·ãªã«åã³
ã±ã€é žå¡©ïŒäžŠã³ã«ç³ïŒäŸãã°ã·ãŠãŒã¯ããŒã¹ãã©
ã¯ããŒã¹åã³ã°ã«ã³ãŒã¹ïŒãä¹³åå€äŸãã°éã€ãª
ã³æ§åã³ã¢ããªã³æ§ä¹³åå€ïŒäŸãã°ããªãªãã·ãš
ãã¬ã³èèªé žãšã¹ãã«ãããªãªãã·ãšãã¬ã³èèª
æã¢ã«ã³ãŒã«ãšãŒãã«ãã¢ã«ãã«ã¹ã«ãããŒãå
ã³ã¢ãªãŒã«ã¹ã«ãããŒãïŒãåæ£å€ïŒäŸãã°ãªã°
ãã³ãäºç¡«é žå»æ¶²ãã¡ãã«ã»ã«ããŒã¹ã殿ç²åã³
ããªããã«ãããªãã³ïŒåã³æœ€æ»å€ïŒäŸãã°ã¹ã
ã¢ãªã³é žãã°ãã·ãŠã ãã¿ã«ã¯ãã¹ãã¢ãªã³é žå
ã³ã©ãŠãªã«ç¡«é žãããªãŠã ïŒã§ããïŒãŸãçµå£çš
éã®å Žåãé å€ã«ã¯å¥œãŸããã¯äžèšã®è³Šåœ¢å€ã«å
ããŠã奜é©ãªæ·»å ç©äŸãã°æ®¿ç²å¥œãŸããã¯ãžã€ã¬
ã€ã¢æ®¿ç²åã³ãŒã©ãã³ãšå ±ã«ã¯ãšã³é žãããªãŠ
ã ãçé žã«ã«ã·ãŠã åã³ãªã³é žäºã«ã«ã·ãŠã ãå«
ãŸããããšãã§ããã ãŸãå šãŠã®è¬å€èª¿è£œç©ã«ã¯çè²å€åã³ä¿åå€äžŠ
ã³ã«è³éŠåã³é¢šå³æ·»å ç©ïŒäŸãã°ã¯ã€ãæ²¹åã³ãŠ
ãŒã«ãªæ²¹ïŒåã³çå³å€ïŒäŸãã°ãµãã«ãªã³ïŒãå«
ãŸããããšãã§ããã 該è¬å€èª¿è£œç©ã¯å šçµæç©ã®ééã«å¯ŸããŠæŽ»æ§æ
åãäžè¬ã«0.5ã90ééïŒ å«æããã æ¬çºæã®ååç©ã«å ããŠãæ¬çºæã®è¬å€èª¿è£œç©
åã³è¬å€ã¯ãŸããä»ã®è¬å€çã«æŽ»æ§ãªååç©ãå«
ãããšãã§ããããŸã該çµæç©ã¯æ¬çºæã®ååç©
ã®è€æ°ãå«ãããšãã§ããã æ¬çºæã®è¬å€ã«ãããä»»æã®åžéå€ã¯æ¬çºæã®
è¬å€èª¿è£œç©ã«ã€ããŠäžã«è¿°ã¹ãããããã®åžéå€
ã§ããããšãã§ããããããè¬å€ã¯åç¬ã®åžéå€
ãšããŠååé200ãããå°ãã溶åªãå«ãããšã
ã§ããã 該è¬å€ãæ§æããåé¢ããäžäœéšåã¯äžè¬ã«ã
ãã®åœ¢ç¶ãŸãã¯å è£ ã®çç±ã«ãããå»è¬æäžã«é©
åãããäžã€äŸãã°æ¬¡ã®ããããã®ãã®ã§ããã
ãšãã§ããïŒé å€ïŒããŒã³ãžåã³é¡ç²ãå«ãïŒã
äžžå€ãç³è¡£äžžãã«ãã»ã«å€ãåè¬åã³ã¢ã³ãã«
å€ããããã®åœ¢æ ã®ãããã®ã¯æŽ»æ§æåãåŸæŸæ§
ã«ããããšãã§ãããã«ãã»ã«å€ã®åŠããã®ã¯ä¿
è·ãšã³ããããå«ã¿ãããã¯è¬å€éšåãç©ççã«
åé¢ãããããŠäžäœã«ãããã æ¬çºæã®è¬å€ã®éèæäžã«å¯Ÿãã奜é©ãªïŒæ¥åœ
ãã®æäžéã¯æŽ»æ§æå2.5ã250mgã§ããããããŠ
çµå£æäžã«å¯ŸããŠã¯æŽ»æ§æåïŒã250mgã§ããã äžèšã®è¬å€èª¿è£œç©åã³è¬å€ã®è£œé ã¯æ¬åéã«ã
ããŠã¯å ¬ç¥ã®æ¹æ³ã«ãã€ãŠãäŸãã°å°ãªããšãïŒ
çš®ã®æŽ»æ§æåãšå°ãªããšãïŒçš®ã®åžéå€ãšãæ··å
ããŠè¬å€èª¿è£œç©ïŒäŸãã°é¡ç²ïŒãã€ããã次ã«è©²
çµæç©ãè¬å€ïŒäŸãã°é å€ïŒã«ããããšã«ãã€ãŠ
è¡ãªãããã æŽã«æ¬çºæã¯æ¬çºæã®ååç©ãåç¬ã§ããŸãã¯
åžéå€ãšã®æ··åç©ãšããŠãæãã¯äžèšè¬å€ã®åœ¢æ
ã§äººéåã³äººé以å€ã®åç©ã«æäžããŠã該åç©ã«
ãããäžèšã®ç æ°ã玡é€ïŒäºé²ãææžåã³æ²»çã
å«ãïŒããæ¹æ³ãæäŸããã æ¬æŽ»æ§ååç©ã¯çµå£çãéçµå£çïŒäŸãã°çè
å ãè ¹è å ãç®äžåã³éèå ïŒãŸãã¯èééšã奜
ãŸããã¯çµå£çãŸãã¯éçµå£çãç¹ã«èäžçãŸã
ã¯éèå ã«æäžããããšãèãããããåŸã€ãŠã
è¬å€èª¿è£œç©åã³è¬å€ã¯äŸãã°çµå£åã³éçµå£æäž
ã«é©åãããã®ã§ãããæ¬æ¹æ³ã«ãããæäžã¯å¥œ
ãŸããã¯çµå£ãŸãã¯éçµå£æäžã§ããã äžè¬ã«å¹æçãªææãåŸãããã«ã¯ã0.001mg
ã10mgïŒKgäœéïŒæ¥ã奜ãŸããã¯0.05ãïŒmgïŒKg
äœéïŒæ¥ã®éã§éèå ã«ãæãã¯0.01ã20mgïŒKg
äœéïŒæ¥ã奜ãŸããã¯0.1ãïŒmgïŒKgïŒäœéïŒæ¥
ã®éã§çµå£çã«æäžããããšãæå©ã§ããããšã
ããã€ããããããªãããæã«ã¯äžèšã®æè¬éå²
åããã¯ãããå¿ èŠããããç¹ã«ãã®ããšã¯åŠçœ®
ãåãã人éãŸãã¯åç©ã®æ§è³ªåã³äœéãåŠçœ®ã«
察ããåã ã®åå¿ã掻æ§æåãæäžãã調補ç©ã®
ã¿ã€ãåã³æäžæ¹æ³äžŠã³ã«ç æ°ã®é²è¡çšåºŠãŸãã¯
æäžãè¡ãééã«äŸåãããããããŠæãå Žåã«
ã¯äžèšã®æå°æè¬éãããå°ãªãéãçšããŠåå
ã§ãããäžæ¹ä»ã®å Žåã«ã¯ææã®ææãåŸããã
ã«ãäžèšã®äžéãè¶ ããªããã°ãªããªãå Žåãèµ·
ãã§ããããå€éã«æäžããå Žåã«ã¯ãïŒæ¥ã«æ°
åã«åããæè¬éã§æäžããããšãæå©ã§ããã æ¬çºæã®ååç©ã®è£œé æ¹æ³ã以äžã®å®æœäŸã«ã
ã€ãŠããã«èª¬æããã å®æœäŸ ïŒ ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâããšãã«
âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžã¡ãã«
ãšã¹ãã« ç¡æ°Žã¡ã¿ããŒã«300mläžã®ïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâããšãã«âã°ã«ã¿ã«é žãžã¡ã
ã«ãšã¹ãã«ã®ãããªãŠã å¡©69.0ïœïŒ0.2ã¢ã«ïŒã®
溶液äžã«â78âã§ä¹Ÿç¥ãªãŸã³ãã該溶液ãéè²ã«
ãªããŸã§ãéå°ã«éããã30ååŸã也ç¥çªçŽ ãé
ããŠãªãŸã³ãé€å»ãããã®æ··åç©ãçªçŽ äžã§â20
âã«å æž©ãããç¡æ°Žã¡ã¿ããŒã«50mläžã®ããã©ãž
ã³æ°Žåç©10ïœïŒ0.2ã¢ã«ïŒã滎äžããæ··åç©ã宀
æž©ã§12æéæ¹æãããåŠçããããã«ãã¡ã¿ããŒ
ã«ãç空äžã§çå»ããæ®æž£ãã¯ãããã«ã ã«æ¡ã
å ¥ããäžæº¶æ§ç©è³ªãå¥ããã液ããã¯ããã
ã«ã ãçå»ããæ®æž£ã«å°éã®ã€ãœãããããŒã«ã
å ããåŸãçæç©ãåŸã ã«æ¶åºããã èç¹187âã åçïŒçè«éã®47ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãããª
ãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³
æ°Žåç©ãšåå¿ãããèç¹176âïŒCHCl3ïŒMeOH
ãçšããŠã·ãªã«ã²ã«äžã§ã¯ãããã°ã©ãã«ããã
åŸãã€ãœãããããŒã«ããçµæ¶ïŒã®ïŒïŒïŒâãžã
ããâïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒ
âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«
ïŒâã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®43ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žãžãšãã«ãšã¹ãã«ã®ãããªãŠã å¡©0.2ã¢
ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢
ã«ãšåå¿ãããèç¹147âïŒã¡ã¿ããŒã«ïŒã®ïŒïŒ
ïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâãããã
ãšãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãž
ãšãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®72.8ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâã€ãœãããã«ïŒâã¡ãã«ãšã¹ãã«ã®
ãããªãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ãã
ã©ãžã³æ°Žåç©0.2ã¢ã«ãšåå¿ãããèç¹193âïŒã·
ãªã«ã²ã«äžã§ã¯ãããã°ã©ãã«ãããåŸãã€ãœã
ããããŒã«ããçµæ¶ïŒã®ïŒïŒïŒâãžãããâïŒâ
ã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããªããž
ã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâã€ãœãããã«ïŒâ
ã¡ãã«ãšã¹ãã«ãåŸãããã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãããª
ãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³
æ°Žåç©0.2ã¢ã«ãšåæ ªãããèç¹174âïŒã€ãœãã
ãããŒã«ïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒ
âïŒïŒâãããããšãã«ïŒâããªããžã³âïŒïŒïŒ
âãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã
åŸãããã åçïŒçè«éã®55ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâïŒÎ²âã¡ããã·ãšãã«ïŒïŒâã€ãœã
ããã«ãšã¹ãã«ã®ãããªãŠã å¡©0.2ã¢ã«ãéå°é
ã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢ã«ãšåå¿ã
ããèç¹146ã148âïŒã·ãªã«ã²ã«äžã§ã¯ãããã°
ã©ãã«ãããåŸãã€ãœãããããŒã«ããçµæ¶åïŒ
ã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ã
ã³é žïŒâã€ãœãããã«ïŒâïŒÎ²âã¡ããã·ãšã
ã«ïŒãšã¹ãã«ãåŸãããã åçïŒçè«éã®19ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žãžã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©0.2ã¢
ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢
ã«ãšåå¿ãããèç¹203ã205âïŒã·ãªã«ã²ã«äžã§
ã¯ãããã°ã©ãã«ãããåŸããšã¿ããŒã«ããçµæ¶
åïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒ
âãããããšãã«ïŒâããªããžã³âïŒïŒïŒâãžã«
ã«ãã³é žãžã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®42ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¯ããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãããª
ãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³
æ°Žåç©0.2ã¢ã«ãšåå¿ãããèç¹139âïŒã·ãªã«ã²
ã«äžã§ã¯ãããã°ã©ãã«ãããåŸãã¡ã¿ããŒã«ã
ãçµæ¶åïŒã®ïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒ
ïŒâãžãããâïŒâã¡ãã«âããªããžã³âïŒïŒïŒ
âãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã
åŸãããã åçïŒçè«éã®51ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâããªãã«ãªãã¡ãã«ã
ãšãã«ïŒâã°ã«ã¿ã«é žãžã¡ãã«ãšã¹ãã«ã®ãããª
ãŠã å¡©0.1ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³
æ°Žåç©0.1ã¢ã«ãšåå¿ãããèç¹205âïŒã¡ã¿ããŒ
ã«ïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒ
âããªãã«ãªãã¡ãã«ããšãã«ïŒâããªããžã³â
ïŒïŒïŒâãžã«ã«ãã³é žãžã¡ãã«ãšã¹ãã«ãåŸãã
ãã åçïŒçè«éã®51ïŒ ã å®æœäŸ 10 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâã€ãœãããã«ïŒâïŒÎ²âã¡ããã·ãš
ãã«ïŒãšã¹ãã«ã®ãããªãŠã å¡©0.1ã¢ã«ãéå°é
ã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.1ã¢ã«ãšåå¿ã
ããèç¹165âïŒã€ãœãããããŒã«ïŒã®ïŒïŒïŒâ
ãžãããâïŒâã¡ãã«âïŒâïŒïŒâãããããšã
ã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâã€
ãœãããã«ïŒâïŒÎ²âã¡ããã·ãšãã«ïŒãšã¹ãã«
ãåŸãããã åçïŒçè«éã®42ïŒ ã å®æœäŸ 11 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒã¯ããããšãã«ïŒâã°ã«
ã¿ã«é žãžã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©0.2ã¢ã«
ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢ã«
ãšåå¿ãããèç¹177âïŒãšã¿ããŒã«ïŒã®ïŒâ
ïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒâãžãããâïŒ
âã¡ãã«ããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžã¡
ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®42ïŒ ã å®æœäŸ 12 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¯ããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâã¡ãã«ïŒâã€ãœãããã«ãšã¹ãã«ã®
ãããªãŠã å¡©0.1ã¢ã«ãéå°éã®ãªãŸã³åã³ãã
ã©ãžã³æ°Žåç©0.1ã¢ã«ãšåå¿ãããèç¹166âïŒã«
ã©ã ã¯ãããã°ã©ãã«ãããåŸããšã¿ããŒã«ãã
çµæ¶åïŒã®ïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒ
âãžãããâïŒâã¡ãã«âããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâã€ãœãããã«ïŒâã¡ãã«ãšã¹ã
ã«ãåŸãããã åçïŒçè«éã®38ïŒ ã å®æœäŸ 13 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâããšã³âïŒâã€ã«âã°ã«ã¿ã«
é žïŒâã¡ãã«ïŒâïŒÎ²âããªãã«ãªããšãã«ïŒãš
ã¹ãã«ã®ãããªãŠã å¡©0.2ã¢ã«ããªãŸã³0.2ã¢ã«å
ã³ããã©ãžã³æ°Žåç©0.2ã¢ã«ãšåå¿ãããèç¹151
âïŒã«ã©ã ã¯ãããã°ã©ãã«ãããåŸããšã¿ããŒ
ã«ããçµæ¶åïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«
âïŒâããšã³âïŒâã€ã«âããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâã¡ãã«ïŒâïŒÎ²âããªãã«ãªã
ãšãã«ïŒãšã¹ãã«ãåŸãããã åçïŒçè«éã®29ïŒ ã å®æœäŸ 14 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¯ããâïŒâãããã
ãšãã«ïŒâã°ã«ã¿ã«é žãžã¡ãã«ãšã¹ãã«ã®ãããª
ãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³
æ°Žåç©0.2ã¢ã«ãšåå¿ãããèç¹193ã194âïŒã¡
ã¿ããŒã«ïŒã®ïŒâïŒïŒâã¯ããâïŒâãããããš
ãã«ïŒâïŒïŒïŒâãžãããâïŒâã¡ãã«âããªã
ãžã³âïŒïŒïŒâãžã«ã«ãã³é žãžã¡ãã«ãšã¹ãã«ã
åŸãããã åçïŒçè«éã®68ïŒ ã å®æœäŸ 15 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâaciâãããâ
ãã³ãŸã€ã«âïŒâïŒïŒâãããããšãã«ïŒâã°ã«
ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ã®ãããªãŠã å¡©0.2
ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2
ã¢ã«ãšåå¿ãããèç¹187âïŒã¡ã¿ããŒã«ïŒã®ïŒïŒ
ïŒâãžãããâïŒâïŒïŒâãããããšãã«ïŒâïŒ
âããšãã«âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é ž
ïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®37ïŒ ã å®æœäŸ 16 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã·ã¢ãããšãã«ïŒâã°
ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãããª
ãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³
æ°Žåç©0.2ã¢ã«ãšåå¿ãããèç¹199âïŒãšã¿ããŒ
ã«ïŒã®ïŒâïŒïŒâã·ã¢ãããšãã«ïŒâïŒïŒïŒâãž
ãããâïŒâã¡ãã«âããªããžã³âïŒïŒïŒâãžã«
ã«ãã³é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ãåŸãã
ãã åçïŒçè«éã®57ïŒ ã å®æœäŸ 17 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¡ããã·ããšãã«ïŒâ
ã°ã«ã¿ã«é žãžã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©0.1
ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.1
ã¢ã«ãšåå¿ãããèç¹154âïŒã€ãœãããããŒã«ïŒ
ã®ïŒïŒïŒâãžãããâïŒâïŒïŒâã¡ããã·ããšã
ã«ïŒâïŒâã¡ãã«âããªããžã³âïŒïŒïŒâãžã«ã«
ãã³é žãžã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®51ïŒ ã å®æœäŸ 18 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâããªãžâïŒâã€ã«âã°ã«ã¿ã«
é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©
0.2ã¢ã«ããªãŸã³0.2ã¢ã«åã³ããã©ãžã³æ°Žåç©0.2
ã¢ã«ãšåå¿ãããèç¹179âïŒã«ã©ã ã¯ãããã°
ã©ãã«ãããåŸãã€ãœãããããŒã«ããçµæ¶åïŒ
ã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâããªãžâ
ïŒâã€ã«âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒ
âãšãã«ïŒâã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®38ïŒ ã å®æœäŸ 19 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšãã«ã®ãããªãŠ
ã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Ž
åç©0.2ã¢ã«ãšåå¿ãããèç¹205ã206âïŒã¡ã¿
ããŒã«ïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâ
ïŒïŒâãããããšãã«ïŒâããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ãåŸ
ãããã åçïŒçè«éã®61ïŒ ã å®æœäŸ 20 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¯ããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâã·ã¯ããã³ãã«ïŒâã¡ãã«ãšã¹ãã«
ã®ãããªãŠã å¡©0.1ã¢ã«ãéå°éã®ãªãŸã³åã³ã
ãã©ãžã³æ°Žåç©0.1ã¢ã«ãšåå¿ãããèç¹152â
ïŒã€ãœãããããŒã«ïŒã®ïŒâïŒïŒâã¯ããããšã
ã«ïŒâïŒïŒïŒâãžãããâïŒâã¡ãã«âããªããž
ã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâã·ã¯ããã³ãã«ïŒ
âã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®46ïŒ ã å®æœäŸ 21 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¯ããâïŒâãããã
ãšãã«ïŒâã°ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšã¹
ãã«ã®ãããªãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³å
ã³ããã©ãžã³0.2ã¢ã«ãšåå¿ãããèç¹169âïŒã¡
ã¿ããŒã«ïŒã®ïŒâïŒïŒâã¯ããâïŒâãããããš
ãã«ïŒâïŒïŒïŒâãžãããâïŒâã¡ãã«âããªã
ãžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ã
ã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®58ïŒ ã å®æœäŸ 22 å®æœäŸïŒã®æ¹æ³ãšåæ§ã«ããŠãïŒâã¢ã»ãã«â
ïŒâaciâãããâïŒâïŒïŒâãããããšãã«ïŒ
âã°ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšãã«0.2ã¢
ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢
ã«ãšåå¿ãããèç¹168ã169âïŒã·ãªã«ã²ã«äžã§
ã¯ãããã°ã©ãã«ãããåŸãã€ãœãããããŒã«ã
ãçµæ¶åïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒ
âïŒïŒâãããããšãã«ïŒâããªããžã³âïŒïŒïŒ
âãžã«ã«ãã³é žïŒâãšãã«ãïŒâã¡ãã«ãšã¹ãã«
ãåŸãããã åçïŒçè«éã®39ïŒ ã å®æœäŸ 23 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâaciâãããâ
ïŒâïŒïŒâãããããšãã«ïŒâïŒâããããªãã«
ã°ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãã
ãªãŠã å¡©0.1ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãž
ã³æ°Žåç©0.1ã¢ã«ãšåå¿ãããèç¹139âïŒãšã¿ã
ãŒã«ïŒã®ïŒâãšãã«âïŒïŒïŒâãžãããâïŒâ
ïŒïŒâãããããšãã«ïŒâããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ãåŸ
ãããã åçïŒçè«éã®55ïŒ ã å®æœäŸ 24 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâaciâãããâ
ïŒâãªããœâïŒâïŒïŒâãããããšãã«ïŒâãã
ãµãã³é žã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©0.1ã¢ã«
ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.1ã¢ã«
ãšåå¿ãããèç¹149âïŒã·ãªã«ã²ã«äžã§ã¯ãã
ãã°ã©ãã«ãããåŸããšã¿ããŒã«ããçµæ¶åïŒã®
ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâãã
ãããšãã«ïŒâããªããžã³âïŒâã«ã«ãã³é žãåŸ
ãããã åçïŒçè«éã®72ïŒ ã å®æœäŸ 25 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâãã«âïŒâã€ã«âã°ã«ã¿ã«é ž
ãžã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©0.2ã¢ã«ãéå°
éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢ã«ãšåå¿
ãããèç¹180âïŒã·ãªã«ã²ã«äžã§ã¯ãããã°ã©
ãã«ãããåŸããšã¿ããŒã«ããçµæ¶åïŒã®ïŒïŒïŒ
âãžãããâïŒâã¡ãã«âïŒâãã«âïŒâã€ã«â
ããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžã¡ãã«ãšã¹
ãã«ãåŸãããã åçïŒçè«éã®62ïŒ ã å®æœäŸ 26 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâãã«âïŒâã€ã«âã°ã«ã¿ã«é ž
ïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©
0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©
0.2ã¢ã«ãšåå¿ãããèç¹165âïŒã·ãªã«ã²ã«äžã§
ã¯ãããã°ã©ãã«ãããåŸããšã¿ããŒã«ããçµæ¶
åïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâãã«
âïŒâã€ã«âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é ž
ïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ãåŸãããã å®æœäŸ 27 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâããªãã«ãªãã¡ãã«ã
ãšãã«ïŒâã°ã«ã¿ã«é žïŒâãšãã«ïŒâïŒÎ²âããª
ãã«ãªããšãã«ïŒãšã¹ãã«ã®ãããªãŠã å¡©0.2ã¢
ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢
ã«ãšåå¿ãããèç¹197âïŒã·ãªã«ã²ã«äžã§ã¯ã
ããã°ã©ãã«ãããåŸãã€ãœãããããŒã«ããçµ
æ¶åïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâ
ïŒïŒâããªãã«ãªããšãã«ããšãã«ïŒâããªããž
ã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ïŒâïŒÎ²â
ããªãã«ãªããšãã«ïŒãšã¹ãã«ãåŸãªããã å®æœäŸ 28 ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ã
ã³é žãžãšãã«ãšã¹ãã«0.1ã¢ã«ã50ïŒ æ°Žæ§ãšã¿ã
ãŒã«150mläžã®KOH0.105ã¢ã«ãšå ±ã«éæµäžã§ïŒ
æéå ç±ããããšã¿ããŒã«ãç空äžã§çå»ããæ°Ž
æ§æ®æž£ãã¯ãããã«ã ã§æœåºããçæç©çžãPHå€
ïŒã®é žæ§ã«ããçæç©ãã¯ãããã«ã ã§æœåºã
ããææ©çžãæ¿çž®ããæ®æž£ããå°éã®ãšã¿ããŒã«
ã§èç¹205âïŒå解ïŒã®ïŒïŒïŒâãžãããâïŒâ
ã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããªããž
ã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ãšã¹ãã«ã
æ¶åºããã åçïŒçè«éã®91ïŒ å®æœäŸ 29 å®æœäŸ28ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâã€ãœãããã«
ïŒâã¡ãã«ãšã¹ãã«0.1ã¢ã«ãKOH0.105ã¢ã«ã§ã±
ã³åããïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâ
ïŒïŒâãããããšãã«ïŒâããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâã€ãœãããã«ãšã¹ãã«ãçæã
ãããèç¹195âïŒãšã¿ããŒã«ïŒã åçïŒçè«éã®92ïŒ ã å®æœäŸ 30 å®æœäŸ28ãšåæ§ã®æ¹æ³ã§ãïŒâïŒïŒâã¯ããã
ãšãã«ïŒïŒïŒïŒâãžãããâïŒâã¡ãã«âããªã
ãžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ã
ã«ãšã¹ãã«ãKOH0.105ã¢ã«ã§ã±ã³åããïŒâ
ïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒâãžãããâïŒ
âã¡ãã«âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒ
âãšãã«ãšã¹ãã«ãçæããããèç¹182âïŒãš
ã¿ããŒã«ïŒã åçïŒçè«éã®89ïŒ ã å®æœäŸ 31 å®æœäŸ28ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžãšãã«ãšã¹ãã«
0.1ã¢ã«ãKOH0.25ã¢ã«ãã±ã³åããïŒïŒïŒâãž
ãããâïŒâã¡ãã«âïŒâïŒïŒâãããããšã
ã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãçæ
ããããèç¹169âïŒåè§£ïŒ åçïŒçè«éã®71ïŒ ã å®æœäŸ 32 ïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒâãžãã
ãâïŒâã¡ãã«âããªããžã³âïŒïŒïŒâãžã«ã«ã
ã³é žïŒâãšãã«ãšã¹ãã«0.1ã¢ã«ãç¡æ°Žã¢ãªã«ã¢
ã«ã³ãŒã«150mläžã§ã埮éã®ïœâãã«ãšã³ã¹ã«ã
ã³é žãæ·»å ããŠ18æééæµäžã§å ç±ãããã¢ã«ã³
ãŒã«ãçå»ããæ®æž£ãã¯ãããã«ã ã«æº¶è§£ããã¯
ãããã«ã 溶液ãéçé žãããªãŠã 溶液ã§æŽæµã
ããã¯ãããã«ã ãèžçºãããåŸãå°éã®ãšã¿ã
ãŒã«ãããèç¹125âã®ïŒâïŒïŒâã¯ããããšã
ã«ïŒâïŒïŒïŒâãžãããâïŒâã¡ãã«âããªããž
ã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâã¢ãªã«ïŒâãšãã«
ãšã¹ãã«ãæ¶åºããã åçïŒçè«éã®82ïŒ ã å®æœäŸ 33 å®æœäŸ32ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ãšã¹ã
ã«0.1ã¢ã«ããã埮éã®ïœâãã«ãšã³ã¹ã«ãã³é ž
ãæ·»å ããŠÎ²ââãã³ãžã«ââã¡ãã«ã¢ãã
ãšã¿ããŒã«100mläžã§100âã«20æéå ç±ããåŸã
èç¹192âïŒã¡ã¿ããŒã«ïŒã®ïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâïŒÎ²ââã
ã³ãžã«ââã¡ãã«ã¢ãããšãã«ïŒïŒâãšãã«ãš
ã¹ãã«ãåŸãããã åçïŒçè«éã®37ïŒ ã å®æœäŸ 34 å®æœäŸ32ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâã€ãœãããã«
ãšã¹ãã«0.1ã¢ã«ãããæ¿ç¡«é žïŒmlãæ·»å ããŠã·
ã¯ããã³ã¿ããŒã«100mläžã§12æé100âã«å ç±ã
ãåŸãèç¹141âïŒã·ãªã«ã²ã«äžã§ã¯ãããã°ã©
ãã«ãããåŸãã¡ã¿ããŒã«ããçµæ¶åïŒã®ïŒïŒïŒ
âãžãããâïŒâã¡ãã«âïŒâïŒïŒâãããããš
ãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâ
ã·ã¯ããã³ãã«ïŒâã€ãœãããã«ãšã¹ãã«ãåŸã
ããã åçïŒçè«éã®69ïŒ ã å®æœäŸ 35 å®æœäŸ32ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ãšã¹ã
ã«ãããæ¿ç¡«é ž0.5mlãæ·»å ããŠïœâã¡ã³ããŒã«
30ïœäžã§12æé100âã«å ç±ããåŸãèç¹136â
ïŒãšã¿ããŒã«ïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«
âïŒâïŒïŒâãããããšãã«ïŒâããªããžã³â
ïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ïŒâïœâã¡ã³ã
ã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®42ïŒ ã å®æœäŸ 36 å®æœäŸ32ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžãšãã«ãšã¹ãã«
0.1ã¢ã«ããã埮éã®ïœâãã«ãšã³ã¹ã«ãã³é žã
æ·»å ããŠã沞隰ã¡ããã·ãšã¿ããŒã«150mläžã§12
æéå ç±ããåŸãèç¹118âïŒã€ãœãããããŒã«ïŒ
ã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ã
ã³é žïŒâãšãã«ïŒâïŒÎ²âã¡ããã·ãšãã«ïŒãšã¹
ãã«ãåŸãããã åçïŒçè«éã®79ïŒ ã å®æœäŸ 37 å®æœäŸ32ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžãšãã«ãšã¹ãã«
0.1ã¢ã«ããã埮éã®ïœâãã«ãšã³ã¹ã«ãã³é žã®
æ·»å ã«ãã€ãŠã沞隰ã¡ããã·ãšã¿ããŒã«äžã§48æ
éå ç±ããåŸãèç¹117âïŒã€ãœãããããŒã«ïŒ
ã®ïŒâïŒïŒâã¯ããããšãã«ïŒïŒïŒïŒâãžããã
âïŒâã¡ãã«âããªããžã³âïŒïŒïŒâãžã«ã«ãã³
é žãžâïŒÎ²âã¡ããã·ãšãã«ïŒãšã¹ãã«ãåŸãã
ãã åçïŒçè«éã®54ïŒ ã å®æœäŸ 38 å¡©åã¡ãã¬ã³20mläžã®ãžã·ã¯ãããã·ã«ã«ã«ã
ãžã€ãã0.05ã¢ã«ãæ°·ã§å·åŽããªãããå¡©åã¡ã
ã¬ã³50mläžã®ïŒâïŒïŒâã¯ããããšãã«ïŒïŒïŒïŒ
âãžãããâïŒâã¡ãã«âããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâãšãã«ãšã¹ãã«0.05ã¢ã«åã³ïŒ
âã¯ããã¢ããªã³0.06ã¢ã«ã«å ãããã®æ··åç©ã
宀枩ã§12æéæ¹æãããæ²æ®¿ç©ãå¥ããææ©çž
ãéçé žãããªãŠã 溶液ã§æŽæµããæ¿çž®ããçã
ãïŒâïŒïŒâã¯ããããšãã«ã«ã«ãã¢ã€ã«ïŒâïŒ
âïŒïŒâã¯ããããšãã«ïŒïŒïŒïŒâãžãããâïŒ
âã¡ãã«âããªããžã³âïŒâã«ã«ãã³é žãšãã«ãš
ã¹ãã«ããšã¿ããŒã«ããçµæ¶åããããèç¹189
âã åçïŒçè«éã®79ïŒ ã å®æœäŸ 39 å®æœäŸ38ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâããªãã«ãªãã¡ãã«ããš
ãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâ
ã¡ãã«ãšã¹ãã«0.05ã¢ã«ããã³ãžã«ã¡ãã«ã¢ãã³
0.06ã¢ã«åã³ãžã·ã¯ãããã·ã«ã«ã«ããžã€ãã
0.05ã¢ã«ãšåå¿ãããèç¹197âïŒãšã¿ããŒã«ïŒ
ã®ïŒâïŒãã³ãžã«âã¡ãã«ã«ã«ãã¢ã€ã«ïŒâïŒïŒ
ïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâããªãã«
ãªãã¡ãã«ããšãã«ïŒâããªããžã³âïŒâã«ã«ã
ã³é žã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®71ïŒ ã ãŸãæ¬çºæã¯æ¬çºæã®æŽ»æ§ååç©ã®è£œå€äžèš±å®¹
ãåŸãçç©åŠçåé§ç©è³ªïŒbioprecursorïŒã«é¢ã
ãã æ¬æ现æžã®ç®çã«å¯Ÿããæ¬çºæã®æŽ»æ§ååç©ã®
ã補å€äžèš±å®¹ãåŸãçç©åŠçåé§ç©è³ªããªãèªã¯ã
æ¬æŽ»æ§ååç©ãšã¯ç°ãªãæ§é åŒãæããååç©ã§
ãããããããåç©ãŸãã¯äººéã«æäžããéãæ£
è ã®äœå ã§è©²æŽ»æ§ååç©ã«è»¢åãããååç©ãæ
å³ããã
ã·ã¢ã«ãã«ãéæäœçŽã¢ã«ãã«ã§çœ®æãããŠããŠ
ãããã·ã¯ãã¢ã«ãã«ãäœçŽã¢ã«ã±ãã«ããŸãã¯
âäœçŽã¢ã«ãã«ââãã³ãžã«ã¢ããäœçŽã¢ã«
ãã«ãè¡šããããã㊠R6åã³R7ã¯çžç°ãªããåã æ°ŽçŽ ååãäœçŽã¢
ã«ãã«ãéæããã²ã³ååã§çœ®æãããŠããŠãã
ãããšãã«ããŸãã¯ãã³ãžã«ãè¡šããïŒ R2ã¯éæäœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ãã·ãã
ãã²ã³ãããªãã«ãªãã¡ãã«ãã·ã¢ããããã¯ã
ããã§çœ®æãããŠããŠãããããšãã«ãããšãã«
ãŸãã¯ããªãžã«ãè¡šããïŒ R3ã¯æ°ŽçŽ ååãŸãã¯åŒCOOR8ã®åºãè¡šããã
ãã㧠R8ã¯æ°ŽçŽ ååãäœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ã
ã·ã¢ã«ãã«ãŸãã¯äœçŽããã¢ã«ãã«ãè¡šããïŒã
ã㊠R4ã¯äœçŽã¢ã«ãã«ãŸãã¯ããšãã«ãè¡šããã ã®ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«ããã«
ååç©ãæäŸãããã æ¬çºæã«ãããååç©ã¯ã埪ç°åšç³»
ïŒcirculationïŒã®åŠçœ®äžŠã³ã«èè žç®¡ãæ³å°¿çæ®åš
管åã³åŒåžåšç®¡ç³»ã®åŠçœ®ã«æçšãªæ°èŠãªçŸ€ã®ç©è³ª
ã§ããããããŠãŸãæ¬ååç©ã¯æççäœçšãæã
ããããããŠæ¬ååç©ã¯è¬å€ã®åéã«ãããŠäŸ¡å€
ãããã®ãšã¿ãªãåŸãã ãŸããæ¬çºæã«åŸãã°ãäžè¬åŒ åŒäžã R1â²ã¯åŒOR5â²ã®åºãè¡šããããã㧠R5â²ã¯äœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ãã·ã¢ã«ãã«ã
éæäœçŽã¢ã«ãã«ã§çœ®æãããŠããŠãããã·ã¯ã
ã¢ã«ãã«ããŸãã¯äœçŽã¢ã«ã±ãã«ãè¡šããïŒ R2ïŒR3åã³R4ã¯åèšã®æå³ãæãïŒãã㊠ã¯ã«ããªã³ãè¡šããïŒç¹ã«ïŒäŸ¡ã®ã«ããªã³ïŒ
äŸãã°æ°ŽçŽ ã€ãªã³ããŸãã¯ã¢ã«ã«ãªéå±ïŒæ®ã«ã
ããªãŠã ãŸãã¯ã«ãªãŠã ïŒãã¢ã³ã¢ããŠã ããã
ã¯ã¢ã«ãã«ã¢ã³ã¢ããŠã ã€ãªã³ãè¡šããã ã®ãããã³é žãäžæŽ»æ§ææ©æº¶åªäžã§ãŸããªãŸã³ãš
åå¿ããN.Kornblumåã³P.A.WabeïŒJ.Org.
Chem.ïŒ38ïŒ1418é 以äžïŒ1973ïŒåç §ïŒœã次ãã§
åŒ ã®ããã©ãžã³ãŸãã¯ããã©ãžã³æ°Žåç©ãšåå¿ãã
ãããšãããªãæ¬çºæã®ååç©ã®è£œé æ¹æ³ãæäŸ
ãããã ããã«ãçããååç©ãããã±ã³åããšã¹ãã«
åããšã¹ãã«äº€æãŸãã¯ã¢ããåã®äžè¬ã«æ¢ç¥ã®
æ¹æ³ã«ãã€ãŠãæ¬çºæã®åŒïŒïŒã®ä»ã®ååç©ã
éæçæãããããšãã§ããã æ¬çºæã«ãããæ°èŠãªïŒïŒïŒâãžãããããªã
ãžã³é¡ã¯äŸ¡å€ããè¬çåŠçç¹æ§ãæããããã®åŸª
ç°åšç³»ã«åãŒãäœçšãé®çïŒSpasmolyticïŒäœçš
åã³æççäœçšã«åºã¥ããæ¬ååç©ã¯æé«è¡å§å€
ïŒantiâhypertensive agentïŒãè¡ç®¡æ¡åŒµå€
ïŒvasodilatorïŒãå åèæ²»çå€ïŒcoronary
therapeuticsïŒãé®çå€åã³æ¶çå€ïŒantiâ
Phlogistic agentïŒãšããŠçšããããšãã§ããã åºçºç©è³ªãšããŠãïŒâã¢ã»ãã«âïŒâaciâã
ããâïŒâïŒïŒâãããããšãã«ïŒâã°ã«ã¿ã«é ž
ãžãšãã«ãšã¹ãã«ã®ãããªãŠã å¡©ããªãŸã³åã³ã
ãã©ãžã³ãçšããå Žåããã®åå¿éçšã¯äŸãšããŠ
次ã®åå¿åŒã«ãã€ãŠç€ºãããšãã§ããã äžèšã®æ¹æ³ã«ããã°ãåŒïŒïŒïŒïŒžïŒïŒšïŒã®ã
ããã³é žãŸãã¯ãã®å¡©ããŸããªãŸã³ãšåå¿ããã
次ã«ãã®çæç©ãããã©ãžã³ãšåå¿ãããŠãåŒ
ïŒïŒã®ïŒïŒïŒâãžãããããªããžã³èªå°äœãç
æãããã æ¬çºæã«åŸã€ãŠåºçºç©è³ªãšããŠçšãããããã³
é žåã³ãã®å¡©ã¯ãäŸãã°ãã€ãªãã³âã«ã«ããã«
ååç©äžãžã®ãããé ¢é žãšã¹ãã«ã®å¡©åºâ觊åªäœ
çšã«ãããã«ãšã«ïŒMichaelïŒä»å ã«ãã€ãŠè£œé
ããããšãã§ããA.Dornowåã³A.FreseïŒ
Ann.Chem.578ïŒ122ïŒ1952ïŒåç §ïŒœã æãåŸãåºçºç©è³ªã®äŸã¯æ¬¡ã®ãã®ã§ããïŒ ïŒâaciâãããâïŒâïŒïŒâãããããšãã«ïŒ
âïŒâãªããœâãããµã³é žãšãã«ãšã¹ãã«ãïŒâ
aciâãããâïŒâãªããœâïŒâïŒïŒâããªãã«
ãªãã¡ãã«ããšãã«ïŒâããã¿ã³é žã·ã¯ããã³ã
ã«ãšã¹ãã«ã®ãããªãŠã å¡©ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¯ããããšãã«ïŒâïŒ
âãªããœâãããµã³é žãšãã«ãšã¹ãã«ã®ãžãšãã«
ã¢ã³ã¢ããŠã å¡©ãåã³ïŒâã¢ã»ãã«âïŒâaciâ
ãããâïŒâããªãžã³âïŒâã€ã«âã°ã«ã¿ã«é žïŒ
âïŒÎ²âã¡ããã·ãšãã«ïŒïŒâã¡ãã«ãšã¹ãã«ã®
ãããªãŠã å¡©ã å¯èœãªåžéå€ã¯å šãŠã®äžæŽ»æ§ææ©æº¶åªã§ããã
ãããã®äžã«ã¯ã奜ãŸããã¯ãã¢ã«ã³ãŒã«äŸãã°
ãšã¿ããŒã«ãã¡ã¿ããŒã«åã³ã€ãœãããããŒã«ïŒ
ãšãŒãã«äŸãã°ãžãªããµã³ããžãšãã«ãšãŒãã«ã
ããã©ããããã©ã³ãã°ãªã³ãŒã«ã¢ãã¡ãã«ãšãŒ
ãã«ãããã¯ã°ãªã³ãŒã«ãžã¡ãã«ãšãŒãã«ïŒãŸã
ã¯ãžã¡ãã«ãã«ã ã¢ããããžã¡ãã«ã¹ã«ããã·
ããã¢ã»ããããªã«ãããªãžã³äžŠã³ã«ãããµã¡ã
ã«ãªã³é žããªã¢ãããªã©ãå«ãŸããã åå¿æž©åºŠã¯å®è³ªçãªç¯å²å ã§å€ããããšãã§ã
ããäžè¬ã«ãã®åå¿â120âä¹è³ïŒ120âéã奜ãŸ
ããã¯â80âä¹è³ïŒ20âéã®ç¯å²ã§è¡ãããã ãã®åå¿ã¯åžžå§äžã§è¡ãããšãã§ãããããã
ããŸãå å§äžã§ãè¡ãããšãã§ãããäžè¬ã«åå¿
ã¯åžžå§äžã§è¡ãããã æ¬çºæã«ãããæ¹æ³ãè¡ãéã«ãåŒïŒïŒã®å
åç©ããŸãé©åœãªæº¶åªäžã«ãŠäœæž©ã§ãªãŸã³åãã
次ã«ãã®çæç©ã宀枩ã§ããã©ãžã³ãŸãã¯ããã©
ãžã³æ°Žåç©ïŒã¢ã«ãšåå¿ãããã æ¬çºæã«ãããç©è³ªã®åé¢åã³ç²Ÿè£œã¯å¥œãŸãã
ã¯ãé©åœã«ã¯äžæº¶æ§ç©è³ªãåé¢ããåŸã溶åªãç
空äžã§çå»ããã¯ãããã°ã©ãã€ãŒã«ãããåŸã«
çµæ¶ç¶æ ã§åŸãããçæç©ãé©åœãªæº¶åªããåçµ
æ¶ãããæ¹æ³ã§è¡ãããã äžèšã®æ¹æ³ã«å ããŠãæŽã«ãæ¬çºæã«ãããå
åç©ã¯ãæ¬çºæã«ãããäžèšã®æ¹æ³ã«ãã€ãŠåŸã
ããïŒïŒïŒâãžãããããªããžã³âã¢ãâåã³ãž
ã«ã«ãã³é žãšã¹ãã«ãããæç®ã«ããæ¢ç¥ã®ã±ã³
åããšã¹ãã«åããšã¹ãã«äº€æãŸãã¯ã¢ããåæ³
OrganikumïŒVEB Deuyscher Verlag der
WissenschaftenïŒBerlin1967åç §ïŒã«ãã€ãŠé©
åœã«è£œé ããããšãã§ããã 次ã®æ¹æ³ã¯ããã«é¢ããåãªãäŸãšããŠç€ºãã
ãšãã§ããïŒ ïœ ã±ã³å ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«ãã³é ž
ãšã¹ãã«ïŒåŒïŒR1ïŒOR5ïŒåã³ïŒïŒïŒâãžã
ããããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãšã¹ãã«
ïŒåŒïŒR1ïŒOR5ïŒR3ïŒCOOR8ïŒãã¢ã«ã«ãªïŒ
åœéã§éžæçã«ã±ã³åããïŒïŒïŒâãžãããããª
ããžã³âïŒâã«ã«ãã³é žïŒåŒïŒR1ïŒOHïŒãç
æãããããšãã§ãããéå°éã®ã¢ã«ã«ã§ã®ã±ã³
åã«ãããïŒïŒïŒâãžãããããªããžã³âïŒïŒïŒ
âãžã«ã«ãã³é žïŒåŒïŒR1ïŒOHïŒR3ïŒCOOHïŒ
ãèªå°ãããã ïœ ãšã¹ãã«å ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«ãã³é ž
ïŒåŒïŒR1ïŒOHïŒãïŒïŒïŒâãžãããããªããžã³
âïŒïŒïŒâãžã«ã«ãã³é žããŒããšã¹ãã«ïŒåŒïŒ
R1ïŒOHïŒR3ïŒCOOR8ãŸãã¯R1ïŒOR5ïŒR3ïŒ
COOHïŒåã³ïŒïŒïŒâãžãããããªããžã³âïŒïŒ
ïŒâãžã«ã«ãã³é žïŒåŒïŒR1ïŒOHïŒR3ïŒ
COOHïŒãã¢ã«ã³ãŒã«ããžã¢ãŸã¢ã«ã«ã³ããžã¢
ã«ãã«ã¹ã«ããšãŒããŸãã¯ã¢ã«ãã«ãã©ã€ããšå
å¿ããã察å¿ãããšã¹ãã«ïŒåŒïŒR1ïŒOR5ïŒ
ãŸãã¯R1ïŒOR5ïŒR3ïŒCOOR8ïŒãçæãããã
ãšãã§ããã ïœ ãšã¹ãã«äº€æ ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«ãã³é ž
ãšã¹ãã«ïŒåŒïŒR1ïŒOR5ïŒãåã³ïŒïŒïŒâãžã
ããããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãšã¹ãã«
ïŒåŒïŒR1ïŒOR5ïŒR3ïŒCOOR8ïŒãã¢ã«ã³ãŒã«
äžã«ãŠé žãŸãã¯å¡©åºè§Šåªäžã§åå¿ããã察å¿ãã
ãšã¹ãã«ãçæãããããšãã§ããã ïœ ã¢ããå ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«ãã³é ž
ïŒåŒïŒR1ïŒOHïŒãïŒïŒïŒâãžãããããªããžã³
âïŒâãžã«ã«ãã³é žãšã¹ãã«ïŒåŒïŒR1ïŒ
OR5ïŒãïŒïŒïŒâãžãããããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žããŒããšã¹ãã«ïŒåŒïŒR1ïŒOHïŒ
R3ïŒCOOR8ïŒãïŒïŒïŒâãžãããããªããžã³â
ïŒïŒïŒâãžã«ã«ãã³é žïŒåŒïŒR1ïŒOHïŒR3ïŒ
COOHïŒåã³ïŒïŒïŒâãžãããããªããžã³âïŒïŒ
ïŒâãžã«ã«ãã³é žãšã¹ãã«ïŒåŒïŒR1ïŒOR5ïŒ
R3ïŒCOOR8ïŒãé©åœãªæº¶åªäžã«ãŠç¬¬äžçŽãŸãã¯
第äºçŽèèªæãŸãã¯è³éŠæã¢ãã³ã§å¯Ÿå¿ããã¢ã
ããŸãã¯ããã©ãžãïŒåŒïŒR1ïŒNR6R7ãŸãã¯
R1ïŒNR6R7ïŒR3ïŒCOOR8ïŒã«è»¢åããããšãã§
ããã å¿è«ãäžèšã®æ¹æ³ã¯ã該åºã«å¯Ÿããç¹å®ã®æå³
ã®å€ã«ãæ¬çºæã«ãããä»ã®ååç©ã®è£œé ã«çšã
ãããšãã§ããã æ¬çºæã«ãããååç©ã¯ç«äœç°æ§äœåœ¢ã§ååš
ãããã®ãã®ã¯é¡åãšããŠæåããïŒãšãã³ããª
ããŒïŒããŸãã¯é¡åãšããŠæåããªãïŒãžã¢ã¹ã
ã¬ãªããŒïŒã®ãã®ã§ãããæ¬çºæã¯å¯Ÿæäœåã³ã©
ã»ã圢ã®åæ¹ã䞊ã³ã«ãžã¢ã¹ãã¬ãªããŒæ··åç©ã«
é¢ããããžã¢ã¹ãã¬ãªããŒãšåæ§ã«ãã©ã»ã圢ã¯
æ¢ç¥ã®æ¹æ³ã«ãããŠåäžã®ç«äœç°æ§äœã§ããåæ
åã«åå²ããããšãã§ããïŒäŸãã°E.L.ElielïŒ
Stereochemistry of Carbon CompoundsïŒ
McGraw HillïŒ1962åç §ïŒã åŸèšã®è£œé å®æœäŸã«å ããŠãæ¬çºæã«ãããŠæ¬¡
ã®æŽ»æ§ååç©ãæããããšãã§ããïŒïŒâãšãã«
ïŒïŒïŒâãžãããâïŒâïŒïŒâãããããšãã«ïŒ
âããªããã³âïŒâã«ã«ãã³é žãšãã«ãšã¹ãã«ã
ïŒâïŒïŒïŒïŒâãžã¯ããããšãã«ïŒâïŒïŒïŒâãž
ãããâïŒâã¡ãã«ããªããžã³âïŒïŒïŒâãžã«ã«
ãã³é žãžã¡ãã«ãšã¹ãã«ãïŒïŒïŒâãžãããâïŒ
âïŒïŒâãšãã«ããšãã«ïŒâïŒâã¡ãã«âããªã
ãžã³âïŒïŒïŒâãžã«ã«ãã³é žãžâïŒÎ²âïœâãã
ãã·ãšãã«ïŒãšã¹ãã«ãïŒâïŒïŒâããã¢ããšã
ã«ïŒâïŒïŒïŒâãžãããâïŒâã¡ãã«âããªããž
ã³âïŒïŒïŒâãžã«ã«ãã³é žãžïŒÎ²âã¡ããã·ãšã
ã«ïŒãšã¹ãã«ãïŒïŒïŒâãžãããâïŒâã¡ãã«â
ïŒâããªãžâïŒâã€ã«âããªããžã³âïŒïŒïŒâãž
ã«ã«ãã³é žãžïŒÎ²âã¡ããã·ãšãã«ïŒãšã¹ãã«ã
ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâããª
ãã«ãªãã¡ãã«ããšãã«ïŒâããªããžã³âïŒïŒïŒ
âãžã«ã«ãã³é žïŒâïŒÎ²âãžã¡ãã«ã¢ãããšã
ã«ïŒïŒâïŒÎ²âããªãã«ãªããã«ïŒãšã¹ãã«ã
ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâããªãžâïŒ
âã€ã«âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâ
ãšãã«ïŒâã¡ãã«ãšã¹ãã«ãïŒâïŒïŒïŒïŒâãžã¯
ããããšãã«ïŒâïŒïŒïŒâãžãããâïŒâã¡ãã«
âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžã€ãœãã
ãã«ãšã¹ãã«ãïŒïŒïŒâãžãããâïŒâïŒïŒïŒïŒ
âãžãããããšãã«ïŒâïŒâã¡ãã«âããªããžã³
âïŒïŒïŒâã«ã«ãã³é žãžãšãã«ãšã¹ãã«ãåã³ïŒ
âïŒïŒâã¯ããâïŒâã¡ãã«ããšãã«ïŒâïŒïŒïŒ
âãžãããâïŒâã¡ãã«âããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã æ¬çºæã«ãããååç©ã¯åºãäžã€çš®ã ã®ç¯å²ã®
è¬çåŠçäœçšãæããã 詳现ã«ã¯ãåç©å®éšã«ãããŠæ¬¡ã®äž»ãªäœçšãç«
蚌ãããïŒ ïŒ éçµå£çãçµå£çåã³èäžçã«æäžããéã
æ¬ååç©ã¯å ç¶èã®é¡èã§äžã€æç¶çãªæ¡åŒµã
èµ·ããããå ç¶èã«å¯Ÿãããã®äœçšã¯ãå¿èã«
ãããè² æ ãæžããåæçãªäºç¡é žå¡©
ïŒnitriteïŒæ§å¹æã«ãã€ãŠåŒ·ãããããæ¬åå
ç©ã¯ãšãã«ã®ãŒç¯çŽã®æå³ã§å¿è代è¬äœçš
ïŒheart metabolismïŒã«åœ±é¿ãäžããããŸãã¯
該äœçšãæ¹åããã ïŒ å¿èã«ãããåºæ¿çæïŒstimulus
formationïŒåã³è奮äŒéç³»ïŒexcitation
conduction systemïŒã®å¿åºæ§ïŒexcitabilityïŒ
ãæžããããåŸã€ãŠæ现åäœçšïŒantiâ
fibrillation actionïŒããããããããã¯æ²»ç
æè¬éã«ãããŠæ€åºããããšãã§ããã ïŒ è管ã®å¹³æ»çã®ç·åŒµç«ïŒtoneïŒãæ¬ååç©ã®
äœçšã«ããèããããæžããããããã®è管â
é®çäœçšã¯å šè管系ã«èµ·ãåŸãããæãã¯å€æ¥
ããè管é åïŒcircumseribed vascular
regionïŒïŒäŸãã°äžæ¢ç¥çµç³»ïŒã«ãããŠå€å°é
é¢ããŠè¡šãããã ïŒ æ¬ååç©ã¯æ®éç·åŒµååã³é«åºŠç·åŒµåã®åç©
ã®è¡å§ãäœäžãããåŸã€ãŠæé«è¡å§å€ãšããŠäœ¿
çšããããšãã§ããã ïŒ æ¬ååç©ã¯åŒ·åºŠã®çèâé®çäœçšãæããã
ã®äœçšã¯èãè žç®¡ãæ³å°¿çæ®åšåã³åŒåžåšç³»ã®
å¹³æ»çã«é¡èã«çŸãããã ïŒ æ¬ååç©ã¯æççäœçšãæããã äžèšã®åŠããæ¬çºæã¯ãŸãæ¬çºæã®ååç©ã®å»
è¬åã³ç£å»è¬ã«ãããçšéã«é¢ããã æ¬çºæã¯ã掻æ§æåãšããŠæ¬çºæã®ååç©ãã
åºäœãŸãã¯æ¶²åããæ°äœã®åžéå€æãã¯è¡šé¢æŽ»æ§
å€ãååšããå Žåãé€ããŠååé200ãããå°ã
ãïŒå¥œãŸããã¯350ãããå°ããïŒæº¶åªä»¥å€ã®æ¶²
äœåžéå€ãšã®æ··åç©ãšããŠå«æããè¬å€èª¿è£œç©ã
æäŸããã æŽã«æ¬çºæã¯ã掻æ§æåãšããŠæ¬çºæã®ååç©
ãç¡èãŸãã¯ççåŠçç匵氎溶液ã®åœ¢æ ã§å«æã
ãè¬å€èª¿è£œç©ãæäŸããã ãŸãæ¬çºæã¯æ¬çºæã®ååç©ãããªãæäžåäœ
圢æ ã«ãããè¬å€ãæäŸããã ãŸãæ¬çºæã¯æ¬çºæã®ååç©ãå«ãã§æãé å€
ãããŒã³ãžïŒlozengeïŒåã³é¡ç²ãå«ãããç³è¡£äžžã
ã«ãã»ã«å€ãäžžå€ãã¢ã³ãã«å€ãŸãã¯åè¬ã®åœ¢æ
ã«ãããè¬å€ãæäŸããã æ¬æ现æžã«ãããŠçšãããè¬å€ããšã¯ãå»è¬æ
äžã«é©ããç©ççã«åé¢ããäžäœã®éšåãæå³ã
ããæ¬æ现æžã«ãããŠçšãããæè¬åäœåœ¢æ ã«ã
ããè¬å€ããšã¯ãæ äœãšã®æ··åç©ãšããŠåã³ïŒãŸ
ãã¯ãšã³ãããïŒenvelopeïŒå ã«å«ãŸããæ¬çº
æã®ååç©ã®ïŒæ¥åœãã®æè¬éãŸãã¯ãã®åæ°
ïŒïŒåãŸã§ïŒãããã¯çŽæ°ïŒ1/40ãŸã§ïŒãåã å«
æããå»è¬æäžã«é©ããç©ççã«åé¢ããäžäœã®
éšåãæå³ããã該è¬å€ãïŒæ¥åœãã®æè¬éãå«
ããæãã¯äŸãã°ïŒæ¥åœãã®æè¬éã®1/2ïŒ1/3ã
ããã¯1/4ãå«ããã«ãã€ãŠãæäžããè¬å€ã¯ã
ãããïŒæ¥ïŒåãŸãã¯äŸãã°ïŒïŒïŒãããã¯ïŒå
ãšãªããã 該è¬å€èª¿è£œç©ã¯äŸãã°ã²ã«ãå¡åžå€ãã¯ãªãŒ
ã ãã¹ãã¬ãŒïŒãšãŒããŸã«ãå«ãïŒãããŒã·ãšã³ã
æ°Žæ§ãããã¯éæ°Žæ§åžéå€äžã®æŽ»æ§æåã®æžæ¿
液ã溶液åã³ä¹³æ¶²ãã·ããããé¡ç²ãŸãã¯ç²æ«ã®
圢æ ããšãããšãã§ããã é å€ãç³è¡£äžžãã«ãã»ã«å€åã³äžžå€ã«æ圢ãã
ããã«é©åãããè¬å€èª¿è£œç©ïŒäŸãã°ç²å€ïŒã«çš
ããåžéå€ãšããŠã¯æ¬¡ã®ãã®ãå«ãŸããïŒ (a)å å¡«å€åã³äŒžå±å€ãäŸãã°æŸ±ç²ãç ç³ããã³
ãããŒã«åã³ã±ã€é žïŒ(b)çµåå€ãäŸãã°ã«ã«ãã
ã·ã«ã¡ãã«ã»ã«ããŒã¹åã³ä»ã®ã»ã«ããŒã¹èªå°
äœãã¢ã«ã®ã³é žå¡©ããŒã©ãã³åã³ããªããã«ãã
ãªãã³ïŒ(c)湿最å€ãäŸãã°ã°ãªã»ãªã³ïŒ(d)厩å£å€
äŸãã°å¯å€©ãçé žã«ã«ã·ãŠã åã³éçé žãããªãŠ
ã ïŒ(e)溶解é 延å€ãäŸãã°ãã©ãã€ã³ïŒ(f)ååžå
ä¿é²å€ãäŸãã°ç¬¬åçŽã¢ã³ã¢ããŠã ååç©ïŒ(g)è¡š
é¢æŽ»æ§å€ãäŸãã°ã»ãã«ã¢ã«ã³ãŒã«ãã°ãªã»ãªã³
ã¢ãã¹ãã¢ã¬ãŒãïŒ(h)åžçæ äœãäŸãã°ã«ãªãªã³
åã³ãã³ããã€ãïŒ(i)最æ»å€ãäŸãã°ã¿ã«ã¯ãã¹
ãã¢ãªã³é žã«ã«ã·ãŠã åã³ã¹ãã¢ãªã³é žãã°ãã·
ãŠã 䞊ã³ã«åºäœã®ããªãšãã¬ã³ã°ãªã³ãŒã«ã æ¬çºæã®è¬å€èª¿è£œç©ããã€ãã€ãé å€ãç³è¡£
äžžãã«ãã»ã«å€åã³äžžå€ã¯ãæ®éã®è¢«èŠããšã³ã
ããåã³ä¿è·åºè³ªãæããããšãã§ãããããã¯
äžéæåå€ãå«ãããšãã§ããããããã¯æŽ»æ§æ
åã®ã¿ãæãã¯å¥œãŸããã¯è žç®¡ã®ç¹å®ã®éšåã«ã
ããŠãå¯èœãªãã°é·æéã«äºã€ãŠæŸåºããããã«
æ§æããããšãã§ããã被èŠããšã³ãããåã³ä¿
è·åºè³ªã¯äŸãã°éåäœç©è³ªãŸãã¯ããŠããã€ãã
ããšãã§ããã ãŸã掻æ§æåãäžèšåžéå€ã®ïŒçš®ãŸãã¯æ°çš®ãš
å ±ã«ãã€ã¯ãã«ãã»ã«ç¶ã«ã€ããããšãã§ããã åè¬ã«æ圢ããããã«é©ããè¬å€èª¿è£œç©ã«çšã
ãåžéå€ã¯ãäŸãã°æ®éã®æ°Žæº¶æ§ãŸãã¯é氎溶æ§
åžéå€ãäŸãã°ããªãšãã¬ã³ã°ãªã³ãŒã«åã³èèª
ïŒäŸãã°ãã³ã³ã¢æ²¹åã³é«çŽãšã¹ãã«ãäŸãã°C16
âèèªé žã«ããC14âã¢ã«ã³ãŒã«ãïŒãŸãã¯ããã
ã®åžéå€ã®æ··åç©ã§ããããšãã§ããã å¡åžå€ãã¯ãªãŒã åã³ã²ã«ã§ããè¬å€èª¿è£œç©ã«
ã¯ãäŸãã°æ®éã®åžéå€ãäŸãã°åç©æ§åã³æ€ç©
æ§èèªãããŠããã©ãã€ã³ã柱ç²ããã©ãã«ã³
ããã»ã«ããŒã¹èªå°äœãããªãšãã¬ã³ã°ãªã³ãŒ
ã«ãã·ãªã³ãŒã³ããã³ããã€ããã±ã€é žãã¿ã«ã¯
åã³é žåäºéãŸãã¯ãããã®ç©è³ªã®æ··åç©ãå«ãŸ
ããããšãã§ããã ç²å€åã³ã¹ãã¬ãŒã§ããè¬å€èª¿è£œç©ã«ã¯ãäŸã
ã°æ®éã®åžéå€ãäŸãã°ã©ã¯ããŒã¹ãã¿ã«ã¯ãã±
ã€é žãæ°Žé žåã¢ã«ãããŠã ãã±ã€é žã«ã«ã·ãŠã å
ã³ããªã¢ããç²æ«ãŸãã¯ãããã®ç©è³ªã®æ··åç©ã
å«ãŸããããšãã§ããããšãŒããŸã«ã¹ãã¬ãŒã«ã¯
äŸãã°æ®éã®åŽå°åºå€äŸãã°ã¯ãããã«ãªãçå
æ°ŽçŽ ãå«ãããããšãã§ããã 溶液åã³ä¹³æ¶²ã§ããè¬å€èª¿è£œç©ã«ã¯ãäŸãã°æ®
éã®åžéå€ïŒå¿è«ãè¡šé¢æŽ»æ§å€ãååšããå Žåã
é€ããŠãååé200以äžã®äžèšã®æº¶åªã¯é€å€ã
ãïŒãäŸãã°æº¶åªã溶解å€åã³ä¹³åå€ãå«ãŸãã
ããšãã§ããïŒãããåžéå€ã®ç¹å®ã®äŸã¯ãæ°Žã
ãšãã«ã¢ã«ã³ãŒã«ãã€ãœãããã«ã¢ã«ã³ãŒã«ãç
é žãšãã«ãé ¢é žãšãã«ããã³ãžã«ã¢ã«ã³ãŒã«ãã
ã³ãžã«ãã³ãŸãšãŒãããããã¬ã³ã°ãªã³ãŒã«ã
ïŒïŒïŒâããã¬ã³ã°ãªã³ãŒã«ããžã¡ãã«ãã«ã ã¢
ãããæ²¹ïŒäŸãã°ç²ç ããèœè±çæ²¹ïŒãã°ãªã»ãª
ã³ãããã©ãããããªããªã«ã¢ã«ã³ãŒã«ãããªãš
ãã¬ã³ã°ãªã³ãŒã«åã³ãœã«ãããŒã«ã®èèªé žãšã¹
ãã«ãŸãã¯ãããã®æ··åç©ã§ããã éçµå£æäžã«å¯ŸããŠã溶液åã³ä¹³æ¶²ã¯ç¡èã«ã
ããŠé©åœã«ã¯è¡æ¶²ç匵ã«ãã¹ãã§ããã æžæ¿æ¶²ã§ããè¬å€èª¿è£œç©ã«ã¯ãæ®éã®åžéå€ã
äŸãã°æ°Žããšãã«ã¢ã«ã³ãŒã«ããããã¬ã³ã°ãªã³
ãŒã«ãè¡šé¢æŽ»æ§å€ïŒäŸãã°ãšããã·ã«åã€ãœã¹ã
ã¢ãªã«ã¢ã«ã³ãŒã«ãããªãªãã·ãšãã¬ã³ãœã«ãã
ãåã³ãœã«ãã¿ã³ãšã¹ãã«ïŒã®åŠã液äœåžéå€ã
埮çµæ¶æ§ã»ã«ããŒã¹ãã¡ã¿æ°Žé žåã¢ã«ãããŠã ã
ãã³ããã€ããå¯å€©åã³ãã©ã¬ã«ã³ããŸãã¯ãã
ãã®æ··åç©ãå«ãŸããããšãã§ããã 奜é©ãªè³Šåœ¢å€ã®äŸã¯ãæ°Žãç¡æ¯æ§ã®ææ©æº¶åªäŸ
ãã°ãã©ãã€ã³ïŒäŸãã°ç³æ²¹çåïŒãæ€ç©æ²¹ïŒäŸ
ãã°èœè±çæ²¹ïŒãŽãæ²¹ïŒãã¢ã«ã³ãŒã«ïŒäŸãã°ãš
ãã«ã¢ã«ã³ãŒã«åã³ã°ãªã»ãªã³ïŒåã³ã°ãªã³ãŒã«
ïŒäŸãã°ãããã¬ã³ã°ãªã³ãŒã«åã³ããªãšãã¬ã³
ã°ãªã³ãŒã«ïŒãåºäœã®è³Šåœ¢å€äŸãã°å€©ç¶å²©ç³ç²æ«
ïŒäŸãã°ã«ãªãªã³ãã¢ã«ãããã¿ã«ã¯åã³ããšãŒ
ã¯ïŒãåæ岩ç³ç²æ«ïŒäŸãã°é«åæ£æ§ã·ãªã«åã³
ã±ã€é žå¡©ïŒäžŠã³ã«ç³ïŒäŸãã°ã·ãŠãŒã¯ããŒã¹ãã©
ã¯ããŒã¹åã³ã°ã«ã³ãŒã¹ïŒãä¹³åå€äŸãã°éã€ãª
ã³æ§åã³ã¢ããªã³æ§ä¹³åå€ïŒäŸãã°ããªãªãã·ãš
ãã¬ã³èèªé žãšã¹ãã«ãããªãªãã·ãšãã¬ã³èèª
æã¢ã«ã³ãŒã«ãšãŒãã«ãã¢ã«ãã«ã¹ã«ãããŒãå
ã³ã¢ãªãŒã«ã¹ã«ãããŒãïŒãåæ£å€ïŒäŸãã°ãªã°
ãã³ãäºç¡«é žå»æ¶²ãã¡ãã«ã»ã«ããŒã¹ã殿ç²åã³
ããªããã«ãããªãã³ïŒåã³æœ€æ»å€ïŒäŸãã°ã¹ã
ã¢ãªã³é žãã°ãã·ãŠã ãã¿ã«ã¯ãã¹ãã¢ãªã³é žå
ã³ã©ãŠãªã«ç¡«é žãããªãŠã ïŒã§ããïŒãŸãçµå£çš
éã®å Žåãé å€ã«ã¯å¥œãŸããã¯äžèšã®è³Šåœ¢å€ã«å
ããŠã奜é©ãªæ·»å ç©äŸãã°æ®¿ç²å¥œãŸããã¯ãžã€ã¬
ã€ã¢æ®¿ç²åã³ãŒã©ãã³ãšå ±ã«ã¯ãšã³é žãããªãŠ
ã ãçé žã«ã«ã·ãŠã åã³ãªã³é žäºã«ã«ã·ãŠã ãå«
ãŸããããšãã§ããã ãŸãå šãŠã®è¬å€èª¿è£œç©ã«ã¯çè²å€åã³ä¿åå€äžŠ
ã³ã«è³éŠåã³é¢šå³æ·»å ç©ïŒäŸãã°ã¯ã€ãæ²¹åã³ãŠ
ãŒã«ãªæ²¹ïŒåã³çå³å€ïŒäŸãã°ãµãã«ãªã³ïŒãå«
ãŸããããšãã§ããã 該è¬å€èª¿è£œç©ã¯å šçµæç©ã®ééã«å¯ŸããŠæŽ»æ§æ
åãäžè¬ã«0.5ã90ééïŒ å«æããã æ¬çºæã®ååç©ã«å ããŠãæ¬çºæã®è¬å€èª¿è£œç©
åã³è¬å€ã¯ãŸããä»ã®è¬å€çã«æŽ»æ§ãªååç©ãå«
ãããšãã§ããããŸã該çµæç©ã¯æ¬çºæã®ååç©
ã®è€æ°ãå«ãããšãã§ããã æ¬çºæã®è¬å€ã«ãããä»»æã®åžéå€ã¯æ¬çºæã®
è¬å€èª¿è£œç©ã«ã€ããŠäžã«è¿°ã¹ãããããã®åžéå€
ã§ããããšãã§ããããããè¬å€ã¯åç¬ã®åžéå€
ãšããŠååé200ãããå°ãã溶åªãå«ãããšã
ã§ããã 該è¬å€ãæ§æããåé¢ããäžäœéšåã¯äžè¬ã«ã
ãã®åœ¢ç¶ãŸãã¯å è£ ã®çç±ã«ãããå»è¬æäžã«é©
åãããäžã€äŸãã°æ¬¡ã®ããããã®ãã®ã§ããã
ãšãã§ããïŒé å€ïŒããŒã³ãžåã³é¡ç²ãå«ãïŒã
äžžå€ãç³è¡£äžžãã«ãã»ã«å€ãåè¬åã³ã¢ã³ãã«
å€ããããã®åœ¢æ ã®ãããã®ã¯æŽ»æ§æåãåŸæŸæ§
ã«ããããšãã§ãããã«ãã»ã«å€ã®åŠããã®ã¯ä¿
è·ãšã³ããããå«ã¿ãããã¯è¬å€éšåãç©ççã«
åé¢ãããããŠäžäœã«ãããã æ¬çºæã®è¬å€ã®éèæäžã«å¯Ÿãã奜é©ãªïŒæ¥åœ
ãã®æäžéã¯æŽ»æ§æå2.5ã250mgã§ããããããŠ
çµå£æäžã«å¯ŸããŠã¯æŽ»æ§æåïŒã250mgã§ããã äžèšã®è¬å€èª¿è£œç©åã³è¬å€ã®è£œé ã¯æ¬åéã«ã
ããŠã¯å ¬ç¥ã®æ¹æ³ã«ãã€ãŠãäŸãã°å°ãªããšãïŒ
çš®ã®æŽ»æ§æåãšå°ãªããšãïŒçš®ã®åžéå€ãšãæ··å
ããŠè¬å€èª¿è£œç©ïŒäŸãã°é¡ç²ïŒãã€ããã次ã«è©²
çµæç©ãè¬å€ïŒäŸãã°é å€ïŒã«ããããšã«ãã€ãŠ
è¡ãªãããã æŽã«æ¬çºæã¯æ¬çºæã®ååç©ãåç¬ã§ããŸãã¯
åžéå€ãšã®æ··åç©ãšããŠãæãã¯äžèšè¬å€ã®åœ¢æ
ã§äººéåã³äººé以å€ã®åç©ã«æäžããŠã該åç©ã«
ãããäžèšã®ç æ°ã玡é€ïŒäºé²ãææžåã³æ²»çã
å«ãïŒããæ¹æ³ãæäŸããã æ¬æŽ»æ§ååç©ã¯çµå£çãéçµå£çïŒäŸãã°çè
å ãè ¹è å ãç®äžåã³éèå ïŒãŸãã¯èééšã奜
ãŸããã¯çµå£çãŸãã¯éçµå£çãç¹ã«èäžçãŸã
ã¯éèå ã«æäžããããšãèãããããåŸã€ãŠã
è¬å€èª¿è£œç©åã³è¬å€ã¯äŸãã°çµå£åã³éçµå£æäž
ã«é©åãããã®ã§ãããæ¬æ¹æ³ã«ãããæäžã¯å¥œ
ãŸããã¯çµå£ãŸãã¯éçµå£æäžã§ããã äžè¬ã«å¹æçãªææãåŸãããã«ã¯ã0.001mg
ã10mgïŒKgäœéïŒæ¥ã奜ãŸããã¯0.05ãïŒmgïŒKg
äœéïŒæ¥ã®éã§éèå ã«ãæãã¯0.01ã20mgïŒKg
äœéïŒæ¥ã奜ãŸããã¯0.1ãïŒmgïŒKgïŒäœéïŒæ¥
ã®éã§çµå£çã«æäžããããšãæå©ã§ããããšã
ããã€ããããããªãããæã«ã¯äžèšã®æè¬éå²
åããã¯ãããå¿ èŠããããç¹ã«ãã®ããšã¯åŠçœ®
ãåãã人éãŸãã¯åç©ã®æ§è³ªåã³äœéãåŠçœ®ã«
察ããåã ã®åå¿ã掻æ§æåãæäžãã調補ç©ã®
ã¿ã€ãåã³æäžæ¹æ³äžŠã³ã«ç æ°ã®é²è¡çšåºŠãŸãã¯
æäžãè¡ãééã«äŸåãããããããŠæãå Žåã«
ã¯äžèšã®æå°æè¬éãããå°ãªãéãçšããŠåå
ã§ãããäžæ¹ä»ã®å Žåã«ã¯ææã®ææãåŸããã
ã«ãäžèšã®äžéãè¶ ããªããã°ãªããªãå Žåãèµ·
ãã§ããããå€éã«æäžããå Žåã«ã¯ãïŒæ¥ã«æ°
åã«åããæè¬éã§æäžããããšãæå©ã§ããã æ¬çºæã®ååç©ã®è£œé æ¹æ³ã以äžã®å®æœäŸã«ã
ã€ãŠããã«èª¬æããã å®æœäŸ ïŒ ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâããšãã«
âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžã¡ãã«
ãšã¹ãã« ç¡æ°Žã¡ã¿ããŒã«300mläžã®ïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâããšãã«âã°ã«ã¿ã«é žãžã¡ã
ã«ãšã¹ãã«ã®ãããªãŠã å¡©69.0ïœïŒ0.2ã¢ã«ïŒã®
溶液äžã«â78âã§ä¹Ÿç¥ãªãŸã³ãã該溶液ãéè²ã«
ãªããŸã§ãéå°ã«éããã30ååŸã也ç¥çªçŽ ãé
ããŠãªãŸã³ãé€å»ãããã®æ··åç©ãçªçŽ äžã§â20
âã«å æž©ãããç¡æ°Žã¡ã¿ããŒã«50mläžã®ããã©ãž
ã³æ°Žåç©10ïœïŒ0.2ã¢ã«ïŒã滎äžããæ··åç©ã宀
æž©ã§12æéæ¹æãããåŠçããããã«ãã¡ã¿ããŒ
ã«ãç空äžã§çå»ããæ®æž£ãã¯ãããã«ã ã«æ¡ã
å ¥ããäžæº¶æ§ç©è³ªãå¥ããã液ããã¯ããã
ã«ã ãçå»ããæ®æž£ã«å°éã®ã€ãœãããããŒã«ã
å ããåŸãçæç©ãåŸã ã«æ¶åºããã èç¹187âã åçïŒçè«éã®47ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãããª
ãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³
æ°Žåç©ãšåå¿ãããèç¹176âïŒCHCl3ïŒMeOH
ãçšããŠã·ãªã«ã²ã«äžã§ã¯ãããã°ã©ãã«ããã
åŸãã€ãœãããããŒã«ããçµæ¶ïŒã®ïŒïŒïŒâãžã
ããâïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒ
âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«
ïŒâã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®43ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žãžãšãã«ãšã¹ãã«ã®ãããªãŠã å¡©0.2ã¢
ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢
ã«ãšåå¿ãããèç¹147âïŒã¡ã¿ããŒã«ïŒã®ïŒïŒ
ïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâãããã
ãšãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãž
ãšãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®72.8ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâã€ãœãããã«ïŒâã¡ãã«ãšã¹ãã«ã®
ãããªãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ãã
ã©ãžã³æ°Žåç©0.2ã¢ã«ãšåå¿ãããèç¹193âïŒã·
ãªã«ã²ã«äžã§ã¯ãããã°ã©ãã«ãããåŸãã€ãœã
ããããŒã«ããçµæ¶ïŒã®ïŒïŒïŒâãžãããâïŒâ
ã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããªããž
ã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâã€ãœãããã«ïŒâ
ã¡ãã«ãšã¹ãã«ãåŸãããã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãããª
ãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³
æ°Žåç©0.2ã¢ã«ãšåæ ªãããèç¹174âïŒã€ãœãã
ãããŒã«ïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒ
âïŒïŒâãããããšãã«ïŒâããªããžã³âïŒïŒïŒ
âãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã
åŸãããã åçïŒçè«éã®55ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâïŒÎ²âã¡ããã·ãšãã«ïŒïŒâã€ãœã
ããã«ãšã¹ãã«ã®ãããªãŠã å¡©0.2ã¢ã«ãéå°é
ã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢ã«ãšåå¿ã
ããèç¹146ã148âïŒã·ãªã«ã²ã«äžã§ã¯ãããã°
ã©ãã«ãããåŸãã€ãœãããããŒã«ããçµæ¶åïŒ
ã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ã
ã³é žïŒâã€ãœãããã«ïŒâïŒÎ²âã¡ããã·ãšã
ã«ïŒãšã¹ãã«ãåŸãããã åçïŒçè«éã®19ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žãžã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©0.2ã¢
ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢
ã«ãšåå¿ãããèç¹203ã205âïŒã·ãªã«ã²ã«äžã§
ã¯ãããã°ã©ãã«ãããåŸããšã¿ããŒã«ããçµæ¶
åïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒ
âãããããšãã«ïŒâããªããžã³âïŒïŒïŒâãžã«
ã«ãã³é žãžã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®42ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¯ããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãããª
ãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³
æ°Žåç©0.2ã¢ã«ãšåå¿ãããèç¹139âïŒã·ãªã«ã²
ã«äžã§ã¯ãããã°ã©ãã«ãããåŸãã¡ã¿ããŒã«ã
ãçµæ¶åïŒã®ïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒ
ïŒâãžãããâïŒâã¡ãã«âããªããžã³âïŒïŒïŒ
âãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã
åŸãããã åçïŒçè«éã®51ïŒ ã å®æœäŸ ïŒ å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâããªãã«ãªãã¡ãã«ã
ãšãã«ïŒâã°ã«ã¿ã«é žãžã¡ãã«ãšã¹ãã«ã®ãããª
ãŠã å¡©0.1ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³
æ°Žåç©0.1ã¢ã«ãšåå¿ãããèç¹205âïŒã¡ã¿ããŒ
ã«ïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒ
âããªãã«ãªãã¡ãã«ããšãã«ïŒâããªããžã³â
ïŒïŒïŒâãžã«ã«ãã³é žãžã¡ãã«ãšã¹ãã«ãåŸãã
ãã åçïŒçè«éã®51ïŒ ã å®æœäŸ 10 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâã€ãœãããã«ïŒâïŒÎ²âã¡ããã·ãš
ãã«ïŒãšã¹ãã«ã®ãããªãŠã å¡©0.1ã¢ã«ãéå°é
ã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.1ã¢ã«ãšåå¿ã
ããèç¹165âïŒã€ãœãããããŒã«ïŒã®ïŒïŒïŒâ
ãžãããâïŒâã¡ãã«âïŒâïŒïŒâãããããšã
ã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâã€
ãœãããã«ïŒâïŒÎ²âã¡ããã·ãšãã«ïŒãšã¹ãã«
ãåŸãããã åçïŒçè«éã®42ïŒ ã å®æœäŸ 11 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒã¯ããããšãã«ïŒâã°ã«
ã¿ã«é žãžã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©0.2ã¢ã«
ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢ã«
ãšåå¿ãããèç¹177âïŒãšã¿ããŒã«ïŒã®ïŒâ
ïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒâãžãããâïŒ
âã¡ãã«ããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžã¡
ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®42ïŒ ã å®æœäŸ 12 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¯ããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâã¡ãã«ïŒâã€ãœãããã«ãšã¹ãã«ã®
ãããªãŠã å¡©0.1ã¢ã«ãéå°éã®ãªãŸã³åã³ãã
ã©ãžã³æ°Žåç©0.1ã¢ã«ãšåå¿ãããèç¹166âïŒã«
ã©ã ã¯ãããã°ã©ãã«ãããåŸããšã¿ããŒã«ãã
çµæ¶åïŒã®ïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒ
âãžãããâïŒâã¡ãã«âããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâã€ãœãããã«ïŒâã¡ãã«ãšã¹ã
ã«ãåŸãããã åçïŒçè«éã®38ïŒ ã å®æœäŸ 13 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâããšã³âïŒâã€ã«âã°ã«ã¿ã«
é žïŒâã¡ãã«ïŒâïŒÎ²âããªãã«ãªããšãã«ïŒãš
ã¹ãã«ã®ãããªãŠã å¡©0.2ã¢ã«ããªãŸã³0.2ã¢ã«å
ã³ããã©ãžã³æ°Žåç©0.2ã¢ã«ãšåå¿ãããèç¹151
âïŒã«ã©ã ã¯ãããã°ã©ãã«ãããåŸããšã¿ããŒ
ã«ããçµæ¶åïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«
âïŒâããšã³âïŒâã€ã«âããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâã¡ãã«ïŒâïŒÎ²âããªãã«ãªã
ãšãã«ïŒãšã¹ãã«ãåŸãããã åçïŒçè«éã®29ïŒ ã å®æœäŸ 14 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¯ããâïŒâãããã
ãšãã«ïŒâã°ã«ã¿ã«é žãžã¡ãã«ãšã¹ãã«ã®ãããª
ãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³
æ°Žåç©0.2ã¢ã«ãšåå¿ãããèç¹193ã194âïŒã¡
ã¿ããŒã«ïŒã®ïŒâïŒïŒâã¯ããâïŒâãããããš
ãã«ïŒâïŒïŒïŒâãžãããâïŒâã¡ãã«âããªã
ãžã³âïŒïŒïŒâãžã«ã«ãã³é žãžã¡ãã«ãšã¹ãã«ã
åŸãããã åçïŒçè«éã®68ïŒ ã å®æœäŸ 15 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâaciâãããâ
ãã³ãŸã€ã«âïŒâïŒïŒâãããããšãã«ïŒâã°ã«
ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ã®ãããªãŠã å¡©0.2
ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2
ã¢ã«ãšåå¿ãããèç¹187âïŒã¡ã¿ããŒã«ïŒã®ïŒïŒ
ïŒâãžãããâïŒâïŒïŒâãããããšãã«ïŒâïŒ
âããšãã«âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é ž
ïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®37ïŒ ã å®æœäŸ 16 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã·ã¢ãããšãã«ïŒâã°
ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãããª
ãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³
æ°Žåç©0.2ã¢ã«ãšåå¿ãããèç¹199âïŒãšã¿ããŒ
ã«ïŒã®ïŒâïŒïŒâã·ã¢ãããšãã«ïŒâïŒïŒïŒâãž
ãããâïŒâã¡ãã«âããªããžã³âïŒïŒïŒâãžã«
ã«ãã³é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ãåŸãã
ãã åçïŒçè«éã®57ïŒ ã å®æœäŸ 17 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¡ããã·ããšãã«ïŒâ
ã°ã«ã¿ã«é žãžã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©0.1
ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.1
ã¢ã«ãšåå¿ãããèç¹154âïŒã€ãœãããããŒã«ïŒ
ã®ïŒïŒïŒâãžãããâïŒâïŒïŒâã¡ããã·ããšã
ã«ïŒâïŒâã¡ãã«âããªããžã³âïŒïŒïŒâãžã«ã«
ãã³é žãžã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®51ïŒ ã å®æœäŸ 18 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâããªãžâïŒâã€ã«âã°ã«ã¿ã«
é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©
0.2ã¢ã«ããªãŸã³0.2ã¢ã«åã³ããã©ãžã³æ°Žåç©0.2
ã¢ã«ãšåå¿ãããèç¹179âïŒã«ã©ã ã¯ãããã°
ã©ãã«ãããåŸãã€ãœãããããŒã«ããçµæ¶åïŒ
ã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâããªãžâ
ïŒâã€ã«âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒ
âãšãã«ïŒâã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®38ïŒ ã å®æœäŸ 19 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâãããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšãã«ã®ãããªãŠ
ã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Ž
åç©0.2ã¢ã«ãšåå¿ãããèç¹205ã206âïŒã¡ã¿
ããŒã«ïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâ
ïŒïŒâãããããšãã«ïŒâããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ãåŸ
ãããã åçïŒçè«éã®61ïŒ ã å®æœäŸ 20 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¯ããããšãã«ïŒâã°
ã«ã¿ã«é žïŒâã·ã¯ããã³ãã«ïŒâã¡ãã«ãšã¹ãã«
ã®ãããªãŠã å¡©0.1ã¢ã«ãéå°éã®ãªãŸã³åã³ã
ãã©ãžã³æ°Žåç©0.1ã¢ã«ãšåå¿ãããèç¹152â
ïŒã€ãœãããããŒã«ïŒã®ïŒâïŒïŒâã¯ããããšã
ã«ïŒâïŒïŒïŒâãžãããâïŒâã¡ãã«âããªããž
ã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâã·ã¯ããã³ãã«ïŒ
âã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®46ïŒ ã å®æœäŸ 21 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâã¯ããâïŒâãããã
ãšãã«ïŒâã°ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšã¹
ãã«ã®ãããªãŠã å¡©0.2ã¢ã«ãéå°éã®ãªãŸã³å
ã³ããã©ãžã³0.2ã¢ã«ãšåå¿ãããèç¹169âïŒã¡
ã¿ããŒã«ïŒã®ïŒâïŒïŒâã¯ããâïŒâãããããš
ãã«ïŒâïŒïŒïŒâãžãããâïŒâã¡ãã«âããªã
ãžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ã
ã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®58ïŒ ã å®æœäŸ 22 å®æœäŸïŒã®æ¹æ³ãšåæ§ã«ããŠãïŒâã¢ã»ãã«â
ïŒâaciâãããâïŒâïŒïŒâãããããšãã«ïŒ
âã°ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšãã«0.2ã¢
ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢
ã«ãšåå¿ãããèç¹168ã169âïŒã·ãªã«ã²ã«äžã§
ã¯ãããã°ã©ãã«ãããåŸãã€ãœãããããŒã«ã
ãçµæ¶åïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒ
âïŒïŒâãããããšãã«ïŒâããªããžã³âïŒïŒïŒ
âãžã«ã«ãã³é žïŒâãšãã«ãïŒâã¡ãã«ãšã¹ãã«
ãåŸãããã åçïŒçè«éã®39ïŒ ã å®æœäŸ 23 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâaciâãããâ
ïŒâïŒïŒâãããããšãã«ïŒâïŒâããããªãã«
ã°ã«ã¿ã«é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãã
ãªãŠã å¡©0.1ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãž
ã³æ°Žåç©0.1ã¢ã«ãšåå¿ãããèç¹139âïŒãšã¿ã
ãŒã«ïŒã®ïŒâãšãã«âïŒïŒïŒâãžãããâïŒâ
ïŒïŒâãããããšãã«ïŒâããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ãåŸ
ãããã åçïŒçè«éã®55ïŒ ã å®æœäŸ 24 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâaciâãããâ
ïŒâãªããœâïŒâïŒïŒâãããããšãã«ïŒâãã
ãµãã³é žã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©0.1ã¢ã«
ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.1ã¢ã«
ãšåå¿ãããèç¹149âïŒã·ãªã«ã²ã«äžã§ã¯ãã
ãã°ã©ãã«ãããåŸããšã¿ããŒã«ããçµæ¶åïŒã®
ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâãã
ãããšãã«ïŒâããªããžã³âïŒâã«ã«ãã³é žãåŸ
ãããã åçïŒçè«éã®72ïŒ ã å®æœäŸ 25 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâãã«âïŒâã€ã«âã°ã«ã¿ã«é ž
ãžã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©0.2ã¢ã«ãéå°
éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢ã«ãšåå¿
ãããèç¹180âïŒã·ãªã«ã²ã«äžã§ã¯ãããã°ã©
ãã«ãããåŸããšã¿ããŒã«ããçµæ¶åïŒã®ïŒïŒïŒ
âãžãããâïŒâã¡ãã«âïŒâãã«âïŒâã€ã«â
ããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžã¡ãã«ãšã¹
ãã«ãåŸãããã åçïŒçè«éã®62ïŒ ã å®æœäŸ 26 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâãã«âïŒâã€ã«âã°ã«ã¿ã«é ž
ïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ã®ãããªãŠã å¡©
0.2ã¢ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©
0.2ã¢ã«ãšåå¿ãããèç¹165âïŒã·ãªã«ã²ã«äžã§
ã¯ãããã°ã©ãã«ãããåŸããšã¿ããŒã«ããçµæ¶
åïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâãã«
âïŒâã€ã«âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é ž
ïŒâãšãã«ïŒâã¡ãã«ãšã¹ãã«ãåŸãããã å®æœäŸ 27 å®æœäŸïŒãšåæ§ã®æ¹æ³ã§ãïŒâã¢ã»ãã«âïŒâ
aciâãããâïŒâïŒïŒâããªãã«ãªãã¡ãã«ã
ãšãã«ïŒâã°ã«ã¿ã«é žïŒâãšãã«ïŒâïŒÎ²âããª
ãã«ãªããšãã«ïŒãšã¹ãã«ã®ãããªãŠã å¡©0.2ã¢
ã«ãéå°éã®ãªãŸã³åã³ããã©ãžã³æ°Žåç©0.2ã¢
ã«ãšåå¿ãããèç¹197âïŒã·ãªã«ã²ã«äžã§ã¯ã
ããã°ã©ãã«ãããåŸãã€ãœãããããŒã«ããçµ
æ¶åïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâ
ïŒïŒâããªãã«ãªããšãã«ããšãã«ïŒâããªããž
ã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ïŒâïŒÎ²â
ããªãã«ãªããšãã«ïŒãšã¹ãã«ãåŸãªããã å®æœäŸ 28 ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ã
ã³é žãžãšãã«ãšã¹ãã«0.1ã¢ã«ã50ïŒ æ°Žæ§ãšã¿ã
ãŒã«150mläžã®KOH0.105ã¢ã«ãšå ±ã«éæµäžã§ïŒ
æéå ç±ããããšã¿ããŒã«ãç空äžã§çå»ããæ°Ž
æ§æ®æž£ãã¯ãããã«ã ã§æœåºããçæç©çžãPHå€
ïŒã®é žæ§ã«ããçæç©ãã¯ãããã«ã ã§æœåºã
ããææ©çžãæ¿çž®ããæ®æž£ããå°éã®ãšã¿ããŒã«
ã§èç¹205âïŒå解ïŒã®ïŒïŒïŒâãžãããâïŒâ
ã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããªããž
ã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ãšã¹ãã«ã
æ¶åºããã åçïŒçè«éã®91ïŒ å®æœäŸ 29 å®æœäŸ28ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâã€ãœãããã«
ïŒâã¡ãã«ãšã¹ãã«0.1ã¢ã«ãKOH0.105ã¢ã«ã§ã±
ã³åããïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâ
ïŒïŒâãããããšãã«ïŒâããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâã€ãœãããã«ãšã¹ãã«ãçæã
ãããèç¹195âïŒãšã¿ããŒã«ïŒã åçïŒçè«éã®92ïŒ ã å®æœäŸ 30 å®æœäŸ28ãšåæ§ã®æ¹æ³ã§ãïŒâïŒïŒâã¯ããã
ãšãã«ïŒïŒïŒïŒâãžãããâïŒâã¡ãã«âããªã
ãžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ïŒâã¡ã
ã«ãšã¹ãã«ãKOH0.105ã¢ã«ã§ã±ã³åããïŒâ
ïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒâãžãããâïŒ
âã¡ãã«âããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒ
âãšãã«ãšã¹ãã«ãçæããããèç¹182âïŒãš
ã¿ããŒã«ïŒã åçïŒçè«éã®89ïŒ ã å®æœäŸ 31 å®æœäŸ28ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžãšãã«ãšã¹ãã«
0.1ã¢ã«ãKOH0.25ã¢ã«ãã±ã³åããïŒïŒïŒâãž
ãããâïŒâã¡ãã«âïŒâïŒïŒâãããããšã
ã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žãçæ
ããããèç¹169âïŒåè§£ïŒ åçïŒçè«éã®71ïŒ ã å®æœäŸ 32 ïŒâïŒïŒâã¯ããããšãã«ïŒâïŒïŒïŒâãžãã
ãâïŒâã¡ãã«âããªããžã³âïŒïŒïŒâãžã«ã«ã
ã³é žïŒâãšãã«ãšã¹ãã«0.1ã¢ã«ãç¡æ°Žã¢ãªã«ã¢
ã«ã³ãŒã«150mläžã§ã埮éã®ïœâãã«ãšã³ã¹ã«ã
ã³é žãæ·»å ããŠ18æééæµäžã§å ç±ãããã¢ã«ã³
ãŒã«ãçå»ããæ®æž£ãã¯ãããã«ã ã«æº¶è§£ããã¯
ãããã«ã 溶液ãéçé žãããªãŠã 溶液ã§æŽæµã
ããã¯ãããã«ã ãèžçºãããåŸãå°éã®ãšã¿ã
ãŒã«ãããèç¹125âã®ïŒâïŒïŒâã¯ããããšã
ã«ïŒâïŒïŒïŒâãžãããâïŒâã¡ãã«âããªããž
ã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâã¢ãªã«ïŒâãšãã«
ãšã¹ãã«ãæ¶åºããã åçïŒçè«éã®82ïŒ ã å®æœäŸ 33 å®æœäŸ32ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ãšã¹ã
ã«0.1ã¢ã«ããã埮éã®ïœâãã«ãšã³ã¹ã«ãã³é ž
ãæ·»å ããŠÎ²ââãã³ãžã«ââã¡ãã«ã¢ãã
ãšã¿ããŒã«100mläžã§100âã«20æéå ç±ããåŸã
èç¹192âïŒã¡ã¿ããŒã«ïŒã®ïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâïŒÎ²ââã
ã³ãžã«ââã¡ãã«ã¢ãããšãã«ïŒïŒâãšãã«ãš
ã¹ãã«ãåŸãããã åçïŒçè«éã®37ïŒ ã å®æœäŸ 34 å®æœäŸ32ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâã€ãœãããã«
ãšã¹ãã«0.1ã¢ã«ãããæ¿ç¡«é žïŒmlãæ·»å ããŠã·
ã¯ããã³ã¿ããŒã«100mläžã§12æé100âã«å ç±ã
ãåŸãèç¹141âïŒã·ãªã«ã²ã«äžã§ã¯ãããã°ã©
ãã«ãããåŸãã¡ã¿ããŒã«ããçµæ¶åïŒã®ïŒïŒïŒ
âãžãããâïŒâã¡ãã«âïŒâïŒïŒâãããããš
ãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâ
ã·ã¯ããã³ãã«ïŒâã€ãœãããã«ãšã¹ãã«ãåŸã
ããã åçïŒçè«éã®69ïŒ ã å®æœäŸ 35 å®æœäŸ32ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ãšã¹ã
ã«ãããæ¿ç¡«é ž0.5mlãæ·»å ããŠïœâã¡ã³ããŒã«
30ïœäžã§12æé100âã«å ç±ããåŸãèç¹136â
ïŒãšã¿ããŒã«ïŒã®ïŒïŒïŒâãžãããâïŒâã¡ãã«
âïŒâïŒïŒâãããããšãã«ïŒâããªããžã³â
ïŒïŒïŒâãžã«ã«ãã³é žïŒâãšãã«ïŒâïœâã¡ã³ã
ã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®42ïŒ ã å®æœäŸ 36 å®æœäŸ32ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžãšãã«ãšã¹ãã«
0.1ã¢ã«ããã埮éã®ïœâãã«ãšã³ã¹ã«ãã³é žã
æ·»å ããŠã沞隰ã¡ããã·ãšã¿ããŒã«150mläžã§12
æéå ç±ããåŸãèç¹118âïŒã€ãœãããããŒã«ïŒ
ã®ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ã
ã³é žïŒâãšãã«ïŒâïŒÎ²âã¡ããã·ãšãã«ïŒãšã¹
ãã«ãåŸãããã åçïŒçè«éã®79ïŒ ã å®æœäŸ 37 å®æœäŸ32ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâããª
ããžã³âïŒïŒïŒâãžã«ã«ãã³é žãžãšãã«ãšã¹ãã«
0.1ã¢ã«ããã埮éã®ïœâãã«ãšã³ã¹ã«ãã³é žã®
æ·»å ã«ãã€ãŠã沞隰ã¡ããã·ãšã¿ããŒã«äžã§48æ
éå ç±ããåŸãèç¹117âïŒã€ãœãããããŒã«ïŒ
ã®ïŒâïŒïŒâã¯ããããšãã«ïŒïŒïŒïŒâãžããã
âïŒâã¡ãã«âããªããžã³âïŒïŒïŒâãžã«ã«ãã³
é žãžâïŒÎ²âã¡ããã·ãšãã«ïŒãšã¹ãã«ãåŸãã
ãã åçïŒçè«éã®54ïŒ ã å®æœäŸ 38 å¡©åã¡ãã¬ã³20mläžã®ãžã·ã¯ãããã·ã«ã«ã«ã
ãžã€ãã0.05ã¢ã«ãæ°·ã§å·åŽããªãããå¡©åã¡ã
ã¬ã³50mläžã®ïŒâïŒïŒâã¯ããããšãã«ïŒïŒïŒïŒ
âãžãããâïŒâã¡ãã«âããªããžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žïŒâãšãã«ãšã¹ãã«0.05ã¢ã«åã³ïŒ
âã¯ããã¢ããªã³0.06ã¢ã«ã«å ãããã®æ··åç©ã
宀枩ã§12æéæ¹æãããæ²æ®¿ç©ãå¥ããææ©çž
ãéçé žãããªãŠã 溶液ã§æŽæµããæ¿çž®ããçã
ãïŒâïŒïŒâã¯ããããšãã«ã«ã«ãã¢ã€ã«ïŒâïŒ
âïŒïŒâã¯ããããšãã«ïŒïŒïŒïŒâãžãããâïŒ
âã¡ãã«âããªããžã³âïŒâã«ã«ãã³é žãšãã«ãš
ã¹ãã«ããšã¿ããŒã«ããçµæ¶åããããèç¹189
âã åçïŒçè«éã®79ïŒ ã å®æœäŸ 39 å®æœäŸ38ãšåæ§ã®æ¹æ³ã§ãïŒïŒïŒâãžãããâ
ïŒâã¡ãã«âïŒâïŒïŒâããªãã«ãªãã¡ãã«ããš
ãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«ãã³é žïŒâ
ã¡ãã«ãšã¹ãã«0.05ã¢ã«ããã³ãžã«ã¡ãã«ã¢ãã³
0.06ã¢ã«åã³ãžã·ã¯ãããã·ã«ã«ã«ããžã€ãã
0.05ã¢ã«ãšåå¿ãããèç¹197âïŒãšã¿ããŒã«ïŒ
ã®ïŒâïŒãã³ãžã«âã¡ãã«ã«ã«ãã¢ã€ã«ïŒâïŒïŒ
ïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâããªãã«
ãªãã¡ãã«ããšãã«ïŒâããªããžã³âïŒâã«ã«ã
ã³é žã¡ãã«ãšã¹ãã«ãåŸãããã åçïŒçè«éã®71ïŒ ã ãŸãæ¬çºæã¯æ¬çºæã®æŽ»æ§ååç©ã®è£œå€äžèš±å®¹
ãåŸãçç©åŠçåé§ç©è³ªïŒbioprecursorïŒã«é¢ã
ãã æ¬æ现æžã®ç®çã«å¯Ÿããæ¬çºæã®æŽ»æ§ååç©ã®
ã補å€äžèš±å®¹ãåŸãçç©åŠçåé§ç©è³ªããªãèªã¯ã
æ¬æŽ»æ§ååç©ãšã¯ç°ãªãæ§é åŒãæããååç©ã§
ãããããããåç©ãŸãã¯äººéã«æäžããéãæ£
è ã®äœå ã§è©²æŽ»æ§ååç©ã«è»¢åãããååç©ãæ
å³ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ åŒäžã R1ã¯åŒOR5ãŸãã¯ãåŒãã®åºãè¡šããã ããã§ã R5ã¯æ°ŽçŽ ååãäœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ã
ã·ã¢ã«ãã«ãéæäœçŽã¢ã«ãã«ã§çœ®æãããŠããŠ
ãããã·ã¯ãã¢ã«ãã«ãäœçŽã¢ã«ã±ãã«ããŸãã¯
âäœçŽã¢ã«ãã«ââãã³ãžã«ã¢ããäœçŽã¢ã«
ãã«ãè¡šããããã㊠R6åã³R7ã¯çžç°ãªããåã æ°ŽçŽ ååãäœçŽã¢
ã«ãã«ãéæããã²ã³ååã§çœ®æãããŠããŠãã
ãããšãã«ããŸãã¯ãã³ãžã«ãè¡šããïŒ R2ã¯éæäœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ãã·ãã
ãã²ã³ãããªãã«ãªãã¡ãã«ãã·ã¢ããããã¯ã
ããã§çœ®æãããŠããŠãããããšãã«ãããšãã«
ãŸãã¯ããªãžã«ãè¡šããïŒ R3ã¯æ°ŽçŽ ååãŸãã¯åŒCOOR8ã®åºãè¡šããã
ãã㧠R8ã¯æ°ŽçŽ ååãäœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ã
ã·ã¢ã«ãã«ãŸãã¯äœçŽããã¢ã«ãã«ãè¡šããïŒã
ã㊠R4ã¯äœçŽã¢ã«ãã«ãŸãã¯ããšãã«ãè¡šããã ã®ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«ããã«
ååç©ã ïŒ ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâ
ãããããšãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«
ãã³é žïŒâãšãã«ïŒâïœâã¡ã³ãã«ãšã¹ãã«ã§ã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ äžè¬åŒ åŒäžã R1ã¯åŒOR5ãŸãã¯ãåŒãã®åºãè¡šããã ããã§ã R5ã¯æ°ŽçŽ ååãäœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ã
ã·ã¢ã«ãã«ãéæäœçŽã¢ã«ãã«ã§çœ®æãããŠããŠ
ãããã·ã¯ãã¢ã«ãã«ãäœçŽã¢ã«ã±ãã«ããŸãã¯
âäœçŽã¢ã«ãã«ââãã³ãžã«ã¢ããäœçŽã¢ã«
ãã«ãè¡šããããã㊠R6åã³R7ã¯çžç°ãªããåã æ°ŽçŽ ååãäœçŽã¢
ã«ãã«ãéæããã²ã³ååã§çœ®æãããŠããŠãã
ãããšãã«ããŸãã¯ãã³ãžã«ãè¡šããïŒ R2ã¯éæäœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ãã·ãã
ãã²ã³ãããªãã«ãªãã¡ãã«ãã·ã¢ããããã¯ã
ããã§çœ®æãããŠããŠãããããšãã«ãããšãã«
ãŸãã¯ããªãžã«ãè¡šããïŒ R3ã¯æ°ŽçŽ ååãŸãã¯åŒCOOR8ã®åºãè¡šããã
ãã㧠R8ã¯æ°ŽçŽ ååãäœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ã
ã·ã¢ã«ãã«ãŸãã¯äœçŽããã¢ã«ãã«ãè¡šããïŒã
ã㊠R4ã¯äœçŽã¢ã«ãã«ãŸãã¯ããšãã«ãè¡šããã ã®ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«ããã«
ååç©ã補é ããã«ããããäžè¬åŒ åŒäžã R1â²ã¯åŒOR5â²ã®åºãè¡šããããã㧠R5â²ã¯äœçŽã¢ã«ãã«ãäœçŽã¢ã«ã³ãã·ã¢ã«ãã«ã
éæäœçŽã¢ã«ãã«ã§çœ®æãããŠããŠãããã·ã¯ã
ã¢ã«ãã«ããŸãã¯äœçŽã¢ã«ã±ãã«ãè¡šããïŒ R2ïŒR3åã³R4ã¯åèšã®æå³ãæãïŒãã㊠ã¯ã«ããªã³ãè¡šããã ã®ãããã³é žãäžæŽ»æ§ææ©æº¶åªäžã§ãªãŸã³ãšåå¿
ããããããŠæ¬¡ãã§ããã©ãžã³ãŸãã¯ããã©ãžã³
æ°Žåç©ãšåå¿ããããããŠå¿ èŠã«å¿ããŠãåŸãã
ãååç©ãã±ã³åããšã¹ãã«åããšã¹ãã«äº€æãŸ
ãã¯ã¢ããåããããšãç¹åŸŽãšããåèšäžè¬åŒ
ïŒïŒã®ïŒïŒïŒâãžãããããªããžã³âïŒâã«ã«
ããã«ååç©ã®è£œé æ¹æ³ã ïŒ ïŒžãæ°ŽçŽ ãã¢ã«ã«ãªéå±ãã¢ã³ã¢ããŠã ãŸã
ã¯ã¢ã«ãã«ã¢ã³ã¢ããŠã ã€ãªã³ãè¡šããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ åå¿ãâ120âãïŒ120âã®æž©åºŠã§è¡ãç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé ãŸãã¯ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ åå¿ãâ80âãïŒ20âã®æž©åºŠã§è¡ãç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ ïŒïŒïŒâãžãããâïŒâã¡ãã«âïŒâïŒïŒâ
ãããããšãã«ïŒâããªããžã³âïŒïŒïŒâãžã«ã«
ãã³é žïŒâãšãã« ïŒâïœâã¡ã³ãã«ãšã¹ãã«ã
補é ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782834624 DE2834624A1 (de) | 1978-08-08 | 1978-08-08 | Neue 1,4-dihydropyridazin-3-carbonsaeurederivate, verfahren zu ihrer herstellung und verwendung als arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5536484A JPS5536484A (en) | 1980-03-14 |
| JPS6317068B2 true JPS6317068B2 (ja) | 1988-04-12 |
Family
ID=6046444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9952479A Granted JPS5536484A (en) | 1978-08-08 | 1979-08-06 | Novel 1*44dihydropyridazinee33carboxylic acid derivative |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4280998A (ja) |
| EP (1) | EP0009560B1 (ja) |
| JP (1) | JPS5536484A (ja) |
| AT (1) | ATE1583T1 (ja) |
| DE (2) | DE2834624A1 (ja) |
| ES (1) | ES483201A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0258603U (ja) * | 1988-10-18 | 1990-04-26 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1983000863A1 (en) * | 1981-09-11 | 1983-03-17 | Diamond Shamrock Corp | Antiinflammatory and analgetic 4-pyridylpyridazin(2h)-3-ones |
| FR2515652B1 (fr) * | 1981-11-03 | 1985-10-25 | Sandoz Sa | Nouveaux derives de la 1,4-dihydropyridazine, leur preparation et medicaments contenant ces derives |
| DE3431700A1 (de) * | 1984-08-29 | 1986-03-13 | Bayer Ag, 5090 Leverkusen | Neue 1,4-dihydro-pyridazin-derivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| GB8530602D0 (en) * | 1985-12-12 | 1986-01-22 | Fujisawa Pharmaceutical Co | Heterocyclic compounds |
-
1978
- 1978-08-08 DE DE19782834624 patent/DE2834624A1/de not_active Withdrawn
-
1979
- 1979-07-18 US US06/058,590 patent/US4280998A/en not_active Expired - Lifetime
- 1979-07-30 DE DE7979102712T patent/DE2963730D1/de not_active Expired
- 1979-07-30 AT AT79102712T patent/ATE1583T1/de not_active IP Right Cessation
- 1979-07-30 EP EP79102712A patent/EP0009560B1/de not_active Expired
- 1979-08-06 JP JP9952479A patent/JPS5536484A/ja active Granted
- 1979-08-07 ES ES483201A patent/ES483201A1/es not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0258603U (ja) * | 1988-10-18 | 1990-04-26 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5536484A (en) | 1980-03-14 |
| ES483201A1 (es) | 1980-05-16 |
| DE2963730D1 (en) | 1982-11-04 |
| ATE1583T1 (de) | 1982-10-15 |
| DE2834624A1 (de) | 1980-02-28 |
| EP0009560B1 (de) | 1982-09-22 |
| EP0009560A1 (de) | 1980-04-16 |
| US4280998A (en) | 1981-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0060674B1 (en) | Dihydropyridine anti-ischaemic and antihypertensive agents, processes for their production, and pharmaceutical compositions containing them | |
| US4248873A (en) | Nitro-substituted 1,4-dihydropyridines, processes for _their production and their medicinal use | |
| US4822798A (en) | Circulation-active 4-phenyl-6-substituted dihydropyrimidines | |
| JPS6025424B2 (ja) | ïŒïŒïŒâãžãããããªãžã³ã«ã«ãã³é žã¢ã©ã«ãã«ãšã¹ãã« | |
| JPS63290874A (ja) | ïŒïŒïŒâãžãããããªãžã³ã«ã«ãã³é žååç©ã®è£œé æ¹æ³ | |
| JPS6241505B2 (ja) | ||
| JPS6136282A (ja) | çªçŽ ãå«ãè€çŽ ç°åŒååç©ãããªãå»è¬åãšãã®è£œé æ¹æ³ | |
| JPS6222985B2 (ja) | ||
| DE2940833A1 (de) | 2-methyl-dihydropyridin-verbindung, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel | |
| HU195833B (en) | Process for producing new pyridyl-carbonyl derivatives of 1,4:3,6-dianhydrohexites and pharmaceutics comprising such active ingredient | |
| CA1185182A (en) | Pharmaceutical compositions containing diethyl-2- methyl-6-propyl-4-(3-nitrophenyl)-1,4- dihydropyridine-3,5-dicarboxylate | |
| EP0107619B1 (en) | Dihydropyrazolo(3,4-b)pyridine derivatives and production thereof | |
| JPS6026106B2 (ja) | ã¢ããã¢ã«ããªãã³ã¢ããâïŒïŒïŒâãžãããããªãžã³åã³ãã®è£œé æ³ | |
| SK47894A3 (en) | 2-amino-4-chinolyl-dihydropyridines, method of their production treatments containing thereof, method of their production, and using of these compounds | |
| JPS6317068B2 (ja) | ||
| JPS59110671A (ja) | ïŒïŒïŒâãžãããããªãžã³èªå°äœ | |
| US4360520A (en) | 1,4-Dihydropyridazine compounds, and their medicinal use | |
| JPS5943460B2 (ja) | ïŒâã¢ããâïŒâãžã¢ã«ãã«ã¢ãããžãããããªãžã³ã®è£œé æ¹æ³ | |
| CS199744B2 (en) | Process for preparing derivatives of 2-hydrazonpropionic acid | |
| DE3432985C2 (ja) | ||
| JPS5911584B2 (ja) | ïŒïŒïŒâãžã¢ããâãžãããããªãžã³é¡ã®è£œé æ³ | |
| FR2501682A1 (fr) | Trifluoromethylphenylpyridines a activite anorexigene, un procede de preparation et compositions pharmaceutiques en contenant | |
| US4348395A (en) | 1,4-Dihydropyridazine compounds | |
| US3760082A (en) | Compositions containing 5-amino-3-ethyl-1-phenyl-4-pyrazolecarboxamides and methods of using the same | |
| EP0254527A2 (en) | Tetracyclic indole derivatives |